Document:

Manufacturing Services Agreement

 Exhibit 10.1 
 Flextronics and Tria Beauty Manufacturing Services Agreement 
 This
Flextronics and Tria Beauty Manufacturing Services Agreement (“Agreement” or “MSA”) is entered into this 19th day of September 2010 (the “Effective Date”) by and between TRIA Beauty, Inc., having its place
of business at 4160 Dublin Blvd., Suite 200, Dublin, CA 94568 (“Customer”), and Flextronics Sales and Marketing, Ltd., having its place of business at Suite 402, St. James Court, St. Denis Street, Port Louis, Mauritius
(“Flextronics”). 
 Customer desires to engage Flextronics to perform manufacturing services as further set
forth in this Agreement. The parties agree as follows: 
  

	1.	DEFINITIONS 

 Flextronics and Customer
agree that capitalized terms shall have the meanings set forth in this Agreement, the Exhibits attached hereto are incorporated herein by reference. 
  

	2.	MANUFACTURING SERVICES 

2.1. Work.  Customer hereby engages Flextronics to perform the work (hereinafter “Work”).
“Work” shall mean to procure Materials and to manufacture, assemble, and test the TRIA Beauty Laser Hair Removal System and any other products as mutually agreed by the parties in writing (hereinafter “Product(s)”)
pursuant to detailed written Specifications. The “Specifications” for each Product or revision of the Product shall include, but are not limited to, bill of materials, designs, schematics, assembly drawings, process documentation,
test specifications, current revision number, and Approved Supplier List as updated from time to time by the customer in writing. The Specifications as provided by Customer and included in Flextronics’s production document management system and
maintained in accordance with the terms of this Agreement are incorporated herein by reference as Exhibit 2.1. This Agreement does not include any new product introduction (NPI) or product prototype services related to the Products. In the event
that Customer requires any such services, the parties will enter into a separate agreement. In case of any conflict between the Specifications and this Agreement, this Agreement shall prevail. 

2.2. Manufacturing Supply Review Meetings. 
 (a)    During the term of this Agreement, the parties shall meet **** or as otherwise determined by the parties (each such meeting, a “Supply Review Meeting” or
“MSR”, **** to ensure that the parties are in agreement with respect to key matters. Such meetings may be conducted in person, by videoconference or by teleconference at such locations as shall be determined by the parties. In-person
meetings will alternate between appropriate offices of each party unless otherwise agreed by the parties. The parties shall each bear all expenses of their respective representatives relating to their participation in such meetings. Unless otherwise
agreed by the parties, each Supply Review Meeting shall be held during the last week of every calendar ****. 

(b)    At each Supply Review Meeting, the parties will: **** 

2.3. Engineering Changes.  Customer may request that Flextronics incorporate engineering changes into the Product
by providing Flextronics with a description of the proposed engineering change sufficient to permit Flextronics to evaluate its feasibility and cost. Flextronics will proceed with engineering changes when the parties have agreed upon the changes to
the Specifications, delivery schedule and Product pricing and the Customer has issued a purchase order for the implementation costs. 
 2.4. Tooling; Non-Recurring Expenses; Software.  Customer shall pay for or obtain and consign to Flextronics any Product-specific tooling, equipment or software and other
reasonably necessary non-recurring expenses, to be set forth in Flextronics’s quotation. All software, product specific tooling, equipment and other non-recurring property that Customer provides to Flextronics or any test software that Customer
engages Flextronics to develop is and shall remain the property of Customer and any intellectual property rights covering or claiming such software, tooling equipment or property shall remain the property of Customer. 

2.5. Cost Reduction Projects.  Flextronics agrees to seek ways to reduce the cost of manufacturing Products by
methods such as elimination of Materials, revision of Specifications, identification of alternate vendors, and re-design of assembly or test methods. Upon implementation of such ways that have been initiated by Flextronics and approved by Customer,
Flextronics will receive **** of the demonstrated cost reduction for ****. Customer will receive **** of the demonstrated cost reduction upon implementation of such ways initiated by Customer. Notwithstanding the foregoing, in the event that
Customer is responsible for making a non-recurring expenditure in order to implement cost reduction procedures (whether initiated by Flextronics or Customer). Customer will receive **** of the demonstrated cost reduction upon implementation.

  
  

**** Certain information on this page has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been
requested with respect to the omitted portions. 

	3.	FORECASTS; ORDERS; FEES; PAYMENT 

 3.1. Forecast.   By the second business day of every month, Customer shall provide Flextronics with a rolling twelve (12) month forecast indicating Customer’s monthly Product
requirements. The first ninety (90) days of the forecast will constitute Customer’s written purchase order for all Work to be completed within the first ninety (90) day period. Such purchase orders will be issued in accordance with
Section 3.2 below. Forecast for periods other than the first 90 day period is non binding except for Inventory purchased in compliance with Section 4.1. 
 3.2. Purchase Orders; Precedence. Each purchase order shall specify Customer’s requirements for Product on a **** basis and shall include requested **** delivery dates. Customer may use
its standard purchase order form submitted in writing or electronically; provided that all purchase orders must reference this Agreement and the applicable Specifications. The parties agree that in the event of a disagreement in terms and
conditions, the terms and conditions contained in this Agreement shall prevail over any terms and conditions of any such purchase order, acknowledgment form or other instrument. 
 Customer shall have the right to purchase any subassembly used in manufacturing a Product from Flextronics at any given time with reasonable expectations on the lead time for delivery. Customer shall
submit a purchase order for any subassembly stating a requested delivery date. The price for such subassembly shall be agreed by the parties, but shall be based on the principles described in Section 3.4(a). 

3.3. Purchase Order Acceptance.   Purchase orders shall normally be deemed accepted by Flextronics, provided
however that Flextronics may reject any purchase order: (a) if the fees reflected in the purchase order are inconsistent with the parties’ agreement with respect to the fees; (b) if the purchase order represents a significant
deviation from the last forecast for the same period, unless such deviation is within the parameters of the Flexibility Table (5.2); or (c) if a purchase order would extend Flextronics’s liability beyond Customer’s approved credit
line. Flextronics shall notify Customer of rejection of any purchase order within **** of receipt of such purchase order. 
 Customer shall have
the right to purchase any subassembly used in manufacturing a Product from Flextronics at any given time with reasonable expectations on the lead time for delivery. Customer shall submit a purchase order for any subassembly stating a requested
delivery date. The price for such subassembly shall be agreed by the parties, but shall be based on the principles described in Section 3.4(a). 
 3.4. Fees; Changes; Taxes. 
 (a)  The fees for Products
will be indicated on the purchase orders issued by Customer and accepted by Flextronics and will be determined according to **** Exhibit 3.4. 

The initial fees shall be as set forth on the Fee List attached hereto and incorporated herein as Exhibit 3.4 (the “Fee List”). If a Fee
List is not attached or completed, then the initial fees shall be determined in accordance with this Section 3.4(a) and set forth in purchase orders issued by Customer and accepted by Flextronics in accordance with the terms of this Agreement.

 (b)  Customer is responsible for additional fees and costs due to: (a) changes to the Specifications;
(b) failure of Customer or its subcontractor to timely provide sufficient quantities or a reasonable quality level of Customer Controlled Materials where applicable to sustain the production schedule; and (c) any pre-approved expediting
charges reasonably necessary because of a change in Customer’s requirements. 
 (c)  The fees may be reviewed
periodically by the parties. Any changes in fees and the timing of such changes **** shall be agreed by the parties, such agreement not to be unreasonably withheld or delayed. By way of example only, the fees may be increased if the market price of
fuels, Materials, equipment, labor and other production costs increase beyond normal variations in pricing or currency exchange rates as demonstrated by Flextronics, or reduced if cycle time or materials pricing is reduced, for example. 

(d)  All fees are exclusive of federal, state and local excise, sales, use, VAT, and similar transfer taxes, and any duties, and
Customer shall be responsible for all such items. Customer shall have no responsibility under this subsection (d) for paying taxes on Flextronics’s net income. 
 (e)  The fee determined in accordance with Section 3.4(a) will be based on the exchange rate(s) for converting the purchase price for Inventory denominated in the Parts Purchase
Currency(ies) into the Functional Currency. The fees will be adjusted, on a monthly basis based on changes in the Exchange Rate(s) as reported on the last business day of each month, for the following month to the extent that such Exchange Rates
change more than **** from the prior month (month prior to event of currency change) (the “Currency Window”). “Exchange Rate(s)” is defined as the closing currency exchange rate(s) as

  
  

**** Certain information on this page has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been
requested with respect to the omitted portions. 

 
reported by Reuters on the last business day of the current month. “Functional Currency” means the currency in which all payments are to be made pursuant to Section 3.5 below.
“Parts Purchase Currency(ies)” means U.S. Dollars, Japanese Yen and/or Euros to the extent such currencies are different from the Functional Currency and are used to purchase Inventory needed for the performance of the Work forecasted to
be completed during the applicable month. 
 3.5. Payment.   Customer agrees to pay all invoices in U.S.
Dollars within thirty (30) days of the date of the invoice. 
 3.6. Late Payment.   Customer agrees
to pay **** monthly interest on all late payments. Furthermore, if Customer is late with payments (i.e. more than **** past due) and Flextronics has reasonable cause to believe Customer may not be able to pay, Flextronics may (a) stop all Work
under this Agreement until assurances of payment satisfactory to Flextronics are received or payment is received; (b) demand prepayment for purchase orders; (c) delay shipments; and (d) to the extent that Flextronics’s personnel
cannot be reassigned to other billable work during such stoppage and/or in the event restart costs are incurred, invoice Customer for additional fees before the Work can resume. Customer agrees to provide all necessary financial information required
by Flextronics from time to time in order to make a proper assessment of the creditworthiness of Customer. 
 3.7. Payment
in Advance.   If Flextronics has reasonable cause to believe that Customer may not be able to meet its financial commitments to Flextronics under the provisions of this Agreement, then Flextronics may require that Customer pay for
all outstanding inventory within 30 days and that the payment terms for all future orders will be cash in advance until such time that Flextronics is satisfied that it is prudent to offer Customer more favorable payment terms. 

3.8. ****. 
  

	4.	MATERIALS PROCUREMENT; CUSTOMER RESPONSIBILITY FOR MATERIALS 

 4.1. Authorization to Procure Materials, Inventory and Special Inventory.   Flextronics will provide **** and will obtain Customer’s agreement. Customer’s accepted
purchase orders and forecast will constitute authorization for Flextronics to procure, without Customer’s prior approval: (a) minimum Inventory to manufacture the Products covered by such purchase orders based on the agreed upon Lead Time
and (b) certain minimum Special Inventory based on Customer’s purchase orders and forecast as follows: Long Lead-Time Materials as required based on the Lead Time when such purchase orders are placed and Minimum Order Inventory.
Flextronics will only purchase Economic Order Quantity with prior approval from Customer. Special Inventory materials as noted in 4.1c will require specific authorization by the Customer and will be noted at the MSR. Customer is not liable for the
purchase of unauthorized inventory. 
 4.2. Customer Controlled Materials.   Customer may direct
Flextronics to purchase Customer Controlled Materials in accordance with the Customer Controlled Materials Terms. Customer acknowledges that the Customer Controlled Materials Terms will directly impact Flextronics’s ability to perform under
this Agreement and to provide Customer with the flexibility Customer is requiring pursuant to the terms of this Agreement. In the event that Flextronics reasonably believes that Customer Controlled Materials Terms will create an additional cost that
is not covered by this Agreement, then Flextronics will notify Customer and the parties will agree to either (a) compensate Flextronics for such additional costs, (b) amend this Agreement to conform to the Customer Controlled Materials
Terms or (c) amend the Customer Controlled Materials Terms to conform to this Agreement, in each case at no additional charge to Flextronics. Customer agrees to provide copies to Flextronics of all Customer Controlled Materials Terms upon the
execution of this Agreement and promptly upon execution of any new agreements with suppliers. Customer agrees not to make any modifications or additions to the Customer Controlled Materials Terms or enter into new Customer Controlled Materials Terms
with suppliers that will negatively impact Flextronics’s procurement activities. 
 4.3. Preferred Supplier.
  Customer shall maintain and provide to Flextronics an Approved Supplier List or “ASL”. Flextronics shall only purchase Materials required to manufacture the Product from suppliers on a current ASL. Customer shall give
Flextronics every opportunity to be included on ASLs for Materials that Flextronics can supply. For purposes of this Section 4.3 only, the term “Flextronics” includes Affiliates of Flextronics. 

4.4. Customer Responsibility for Inventory and Special Inventory.   Customer is responsible under the conditions
provided in this Agreement for the cost of all Materials, Inventory and Special Inventory purchased by Flextronics in compliance with and pursuant to this Section 4. 

  
  

**** Certain information on this page has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been
requested with respect to the omitted portions. 

 4.5. Materials Warranties.   Flextronics shall use reasonable
commercial efforts to obtain and pass through to Customer the following warranties with regard to the Materials (other than the Production Materials): (a) conformance of the Materials with both the vendor’s specifications and with the
Specifications, if defined; (b) that the Materials will be free from defects in workmanship; (c) that the Materials will comply with Environmental Regulations; and (d) that the Materials will not infringe the intellectual property
rights of third parties. In the event that Flextronics is unable to obtain and pass through to Customer warranties with regard to the Materials (other than the Production Materials), Flextronics shall so notify Customer in writing. 

 

	5.	SHIPMENTS, SCHEDULE CHANGE, CANCELLATION, STORAGE, INVENTORY MANAGEMENT 

 5.1. Shipments.   All Products delivered pursuant to the terms of this Agreement shall be suitably packed for shipment in accordance with the Specifications and marked for shipment
to Customer’s destination specified in the applicable purchase order. Shipments will be made EXW (Ex-Works, Incoterms 2000) Flextronics’s facility, at which time risk of loss and title will pass to Customer. All freight, insurance and
other shipping expenses, as well as any special packing expenses not included in the original quotation for the Products, will be paid by Customer. In the event Customer designates a freight carrier to be utilized by Flextronics, Customer agrees to
designate only freight carriers that are currently in compliance with all applicable laws relating to anti-terrorism security measures and to adhere to the C-TPAT (Customs-Trade Partnership Against Terrorism) security recommendations and guidelines
as outlined by the United States Bureau of Customs and Border Protection and to prohibit the freight carriage to be sub-contracted to any carrier that is not in compliance with the C-TPAT guidelines. 

5.2. Quantity Increases and Shipment Schedule Changes. 

(a)  For any accepted purchase order, Customer may: (i) increase the quantity of Products or (ii) reschedule the
quantity of Products and their shipment date as provided in the flexibility table below (the “Flexibility Table”): 
  

							
	Maximum Allowable Variance From Accepted Purchase Order Quantities/Shipment Dates
				
	 # of days before
 Shipment Date

 on Purchase Order
	  	 Allowable
 Quantity

 Increases
	  	Maximum
 Reschedule 

Quantity
	  	Maximum
 Reschedule 

Period

				
	0-14	  	0%	  	0%	  	0
				
	15-30	  	0%	  	0%	  	0
				
	31-****	  	30%	  	****	  	****
				
	****	  	50%	  	****	  	****

 Any decrease in quantity is considered a cancellation, unless the decreased quantity is rescheduled for
delivery at a later date in accordance with the Flexibility Table. Quantity cancellations are governed by the terms of Section 5.3 below. Any purchase order quantities increased or rescheduled pursuant to this Section 5.2 (a) may not
be subsequently increased or rescheduled. The Flexibility Table may be amended during the term of this Agreement as may be required and agreed to in writing by both parties and without the need to amend this Agreement. 

(b)  All Purchase Order reschedules to extend delivery dates outside of the Flexibility Table in subsection (a) require
that Customer will pay Flextronics, in accordance with Sections 3.5 and 5.4, the Monthly Charges for any such reschedule, calculated as of the first day after such reschedule for any Inventory and/or Special Inventory that was procured by
Flextronics to support the original delivery schedule that is not used to manufacture Product pursuant to an accepted purchase order within **** of such reschedule. In addition, if Flextronics notifies Customer that such Inventory and/or Special
Inventory has remained in Flextronics’s possession for more than **** since such reschedule, then Customer agrees to immediately purchase any affected Inventory and/or Special Inventory upon receipt of the notice by paying the Affected
Inventory Costs, in accordance with Section 3.5. In addition, any finished Products that have already been manufactured to support the original delivery schedule will be treated as cancelled as provided in Sections 5.3 and 5.4 below. All
reschedules to receive delivery sooner than the original delivery date require Flextronics’s prior written approval, which may not be unreasonably withheld or delayed. If Flextronics agrees to meet an earlier delivery date, and there are extra
costs to meet such date, Flextronics will inform Customer of such costs for Customer’s acceptance and approval in advance of incurring any such costs. In addition, if there are repeated instances in which Customer reschedules orders outside of
the Flexibility Table as described in this Section 

  
  

**** Certain information on this page has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been
requested with respect to the omitted portions. 

 
5.2(b), increases the quantity of orders in excess of the Flexibility Table as described in Section 5.2(c) or cancels orders as described in Section 5.3, resulting in special
circumstances materially impacting the ability of Flextronics to perform its obligations under this Agreement, then, upon the request of Flextronics, the parties will promptly meet to discuss and negotiate in good faith an appropriate resolution of
the situation. 
 (c)  Flextronics will use reasonable commercial efforts to meet any quantity increases, which are
subject to Materials and capacity availability. All quantity increases outside of the Flexibility Table in subsection (a) require Flextronics’s approval, which, in its sole discretion, may or may not be granted. If Flextronics agrees to
accept an increase in quantities in excess of the Flexibility Table in subsection (a) and if there are extra costs to meet such increase, Flextronics will inform Customer for its acceptance and approval in advance of incurring any such costs.

 (d)  Any delays in the normal production or interruption in the workflow process caused by Customer’s changes
to the Specifications or failure to provide sufficient quantities or a reasonable quality level of Customer Controlled Materials where applicable to sustain the production schedule, will be considered a reschedule of any affected purchase orders for
purposes of this Section 5.2. 
 (e)  For purposes of calculating the amount of Inventory and Special Inventory
subject to subsection (b), the “Lead Time” shall be calculated as the Lead Time at the time of procurement of the Inventory and Special Inventory. 
 5.3. Cancellation of Orders and Customer Responsibility for Inventory. 
 (a)  If Customer cancels all or any portion of Product quantity specified in the first **** of an accepted purchase order, then Customer will pay Flextronics, in accordance with Section 3.5
and 5.4, Monthly Charges for any such cancellation, calculated as of the first day after such cancellation for any Product or Inventory or Special Inventory procured by Flextronics to support the original delivery schedule. In addition, if
Flextronics notifies Customer that such Product, Inventory and/or Special Inventory has remained in Flextronics’s possession for more than **** since such cancellation, then Customer agrees to immediately purchase from Flextronics such Product,
Inventory and/or Special Inventory by paying the Affected Inventory Costs, in accordance with Section 3.5. Customer may cancel all or any portion of Product quantity specified after **** of an accepted purchase order without Flextronics’s
prior written approval; provided that, subject to Section 5.4, Customer shall be responsible for the Cost of any Product, Inventory and/or Special Inventory purchased by Flextronics in compliance with and pursuant to Section 4 in order to
manufacture the quantities of Product specified in such purchase order. 
 (b)  If the forecast for any period is less
than the previous forecast supplied covering the same period, the difference between such forecasts will be considered canceled and Customer will be responsible for any Special Inventory purchased or ordered by Flextronics to support such previous
forecast to the extent provided in Sections 4.1 and 5.4. 
 (c)  Products that have been ordered by Customer and that
have not been picked up in accordance with the agreed upon shipment dates shall be considered cancelled and Customer will be responsible for such Products in the same manner as set forth above in Section 5.3(a). 

(d)  For purposes of calculating the amount of Inventory and Special Inventory subject to subsection (a), the “Lead
Time” shall be calculated as the Lead Time as documented at the MSR. 
 5.4. E&O Inventory Disposition
Process.   At each Supply Review Meeting, the parties will identify and agree upon E&O Inventory. As shown on Exhibit 4.1a, the parties will have no more than **** to carry out any agreed upon mitigation plan to reduce exposure
from such E&O Inventory. Such mitigation plan may include, for example and without limitation the following: (a) returning unused Inventory and Special Inventory (to the extent it is returnable), (b) canceling pending orders for
Materials (to the extent orders for Materials are cancelable), (c) using Inventory to manufacture Products to meet Customer’s future needs or other Customers’ products or (d) reworking inventory to be suitable for customer use or
other customer’s products (at mutually agreed upon cost). If, after these ****, there is remaining E&O Inventory, then Customer will be responsible for all such E&O Inventory to the extent such E&O Inventory was purchased by
Flextronics based on MRP Demand and in compliance with Section 4. Flextronics shall invoice Customer for the Cost of such remaining E&O Inventory and Customer shall pay in accordance with Section 3.5. Upon payment by Customer,
Flextronics shall, at Customer’s sole option, either ship, at Customer’s expense, such remaining E&O Inventory to Customer or dispose of such remaining E&O Inventory in a commercially reasonable manner approved by the Customer and
credit or reimburse, as applicable, Customer any monies received from third parties. 

  
  

**** Certain information on this page has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been
requested with respect to the omitted portions. 

 5.5. No Waiver. For the avoidance of doubt, Flextronics’s failure to
invoice Customer for any of the charges set forth in this Section 5 does not constitute a waiver of Flextronics’s right to charge Customer for the same event or other similar events in the future. 

 

	6.	PRODUCT ACCEPTANCE AND EXPRESS LIMITED WARRANTY 

 6.1. Product Acceptance  
 (a)  The Products delivered by
Flextronics will be inspected and tested as required by Customer within **** of receipt at the “ship to” location on the applicable purchase order. If Products do not comply with the express limited warranty set forth in Section 6.2
below, Customer has the right to reject such Products during said period. Products not rejected during said period will be deemed accepted. Customer may return defective Products, freight collect, after obtaining a return material authorization
number from Flextronics to be displayed on the shipping container and completing a failure report. Rejected Products will be promptly repaired or replaced, at Flextronics’s option, and returned freight pre-paid. Customer shall bear all of the
risk, and all costs and expenses, associated with Products that have been returned to Flextronics for which there is no defect found, subject to Section 6.1(b). 
 (b)  Flextronics and Customer agree to consult with each other to explain and resolve any discrepancies between delivered Product and the limited warranty set forth in Section 6.2(a) In the
event that Flextronics and Customer disagree as to whether any Product complies with such limited warranty despite good faith efforts to resolve such discrepancies **** Customer shall bear all of the risk, and all costs and expenses, associated with
Products that have been returned to Flextronics **** 
 6.2. Express Limited Warranty.    This
Section 6.2 sets forth Flextronics’s sole and exclusive warranty and Customer’s sole and exclusive remedies with respect to a breach by Flextronics of such warranty. 

(a)  Flextronics hereby warrants to Customer that the Products will have been manufactured in accordance with the Specifications
and will be free from defects in workmanship for a period of **** from the date of shipment. 
 (b)  Notwithstanding
anything else in this Agreement, this express limited warranty does not apply to, and Flextronics makes no representations or warranties whatsoever with respect to: (i) Materials and/or Customer Controlled Materials; (ii) defects resulting
from the Specifications or the design of the Products; (iii) Product that has been abused, damaged, altered or misused by any person or entity after title passes to Customer; (iv) first articles, prototypes, pre-production units, test
units or other similar Products; (v) defects resulting from tooling, designs or instructions produced or supplied by Customer, or (vi) the compliance of Materials or Products with any Environmental Regulations. Customer shall be liable for
costs or expenses incurred by Flextronics related to the foregoing exclusions to Flextronics’s express limited warranty to the extent provided in Section 10.2. 
 (c)  Upon any failure of a Product to comply with this express limited warranty, Flextronics’s sole obligation, and Customer’s sole remedy, is for Flextronics, at its option, to
promptly repair or replace such unit and return it to Customer freight prepaid. Customer shall return defective Products covered by this warranty freight collect after completing a failure report and obtaining a return material authorization number
from Flextronics to be displayed on the shipping container. Customer shall bear all of the risk, and all costs and expenses, associated with Products that have been returned to Flextronics for which there is no defect found, subject to
Section 6.1(b). 
 (d)  Customer will provide its own warranties directly to any of its end users or other third
parties. Customer will not pass through to end users or other third parties the warranties made by Flextronics under this Agreement. Furthermore, Customer will not make any representations to end users or other third parties on behalf of
Flextronics, and Customer will expressly indicate that the end users and third parties must look solely to Customer in connection with any problems, warranty claim or other matters concerning the Product. In the event that Flextronics receives any
claims or complaints regarding the Product from end users or other third parties, Flextronics shall promptly notify Customer of such claims or complaints. 
 6.3. Representations and Covenants of Flextronics.    Flextronics hereby represents and covenants to Customer that: (a) the Products will have been manufactured, stored
and shipped in accordance with all laws, rules, and regulations that are applicable to the manufacturing site, including standards established by the FDA for current Good Manufacturing Practices, as specified in the QSR and ISO 13485 ****.

 6.4. Mutual Representations and Warranties.    As of the Effective Date, each of Flextronics
and the Customer represent and warrant to the other as follows: 
 (a)  it is a corporation duly organized and validly
existing under the laws of the state or other jurisdiction in which it is incorporated; 

  
  

**** Certain information on this page has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been
requested with respect to the omitted portions. 

 (b)  the execution, delivery and performance of this Agreement by such party has
been duly authorized by all requisite corporate action; 
 (c)  it has the power and authority to execute and deliver
this Agreement and to perform its obligations hereunder; 
 (d)  the execution, delivery and performance by such party
of this Agreement and its compliance with the terms hereof does not and will not conflict with or result in a breach of any term of, or constitute a default under, any agreement or instrument binding or affecting it or its property; and 

(e)  this Agreement has been duly executed and delivered and constitutes such party’s legal, valid and binding obligation
enforceable against it in accordance with its terms. 
 6.5. No Representations or Other Warranties.
  EXCEPT FOR THE REPRESENTATIONS AND WARRANTIES SET FORTH IN SECTIONS 6.2, 6.3 AND 6.4, NEITHER PARTY MAKES ANY REPRESENTATIONS OR WARRANTIES OF ANY KIND WITH REGARD TO THE PERFORMANCE OF THE WORK HEREUNDER OR THE PRODUCTS, EXPRESS,
IMPLIED, STATUTORY, OR IN ANY OTHER PROVISION OF THIS AGREEMENT OR COMMUNICATION WITH CUSTOMER, INCLUDING THE IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR NON-INFRINGEMENT. 

 

	7.	QUALITY 

 7.1.
Standards.   During the term of this Agreement, Flextronics shall manufacture the Products in accordance with the Specifications, including without limitation the QSR and ISO 13485, as may be amended from time to time.
Flextronics also shall be certified to ****. 
 7.2. Regulatory Audits.   Flextronics shall promptly
notify Customer when an FDA inspection of its facilities, or an inspection by third parties in accordance with FDA regulations, or inspection by a Notified Body, related to the Product(s) is expected and/or underway. Flextronics shall also provide
the Customer the option of attending the Audit if it pertains to Customer’s products. Flextronics shall promptly provide Customer with copies of all related correspondence, including without limitation audit reports, Form FDA 483s, Warning
Letters, and any related correspondence with FDA or the Notified Body, as applicable. 
 7.3. Operations, Quality and
Supply Chain Reporting.   The parties will work together in good faith to define quality control processes relating to the Products, including: ****. 
 7.4. Production and Process Controls.   Flextronics shall develop, conduct, control and monitor product processes to ensure that the Product(s) conform to the Specifications and
were produced in substantial compliance with the QSR and ISO 13485. 
 7.5. Packaging Control.   The
parties shall collaborate to ensure that the packaging and shipping containers for the Product(s) are designed and constructed to protect the Product(s) from alteration or damage during the customary conditions of processing, storage, handling or
shipping in substantial compliance with and ISO 13485. 
 7.6. Corrective and Preventive Actions.
  Flextronics hereby agrees to establish and maintain procedures for implementing corrective and preventive actions in substantial compliance with QSR to determine the root cause of quality problems, identifying corrective actions, and
assuring their implementation and effectiveness. Where necessary, Flextronics shall implement corrective actions ****. 
 7.7.
Complaint Investigation.   Flextronics shall, at Customer’s request, assist with Customer’s investigation of Product complaints received from Customer’s customers to the extent that such complaints may
reasonably pertain to Flextronics’s manufacture of the Products. 
 7.8. Records.   Each party shall
create and maintain records for the activities for which they are responsible under this Agreement in substantial compliance with the QSR. Flextronics shall create and maintain Device History Records that demonstrate that the Product(s) was
manufactured in accordance with the Device Master Record and the QSR requirements. 
 7.9. Product and Manufacturing
Modifications.   Either party may propose a product design or manufacturing modification. Customer shall be responsible for making the final decision as to whether a proposed design or manufacturing change may be implemented for
the Product(s). Flextronics is not permitted to make any modifications or manufacturing change that affects the Product(s) without Customer’s prior written approval. Customer shall be responsible for making the final determination as to whether
such changes require regulatory approval or clearance prior to implementation and shall be responsible for filing and obtaining any required approvals and/or clearances. 

  
  

**** Certain information on this page has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been
requested with respect to the omitted portions. 

 7.10. Customer Audits and Inspections.   Flextronics shall provide
Customer reasonable access upon prior notice to inspect, review and audit the manufacturing facilities where the Product(s) is tested, handled, stored, distributed, and/or manufactured to determine if the Product(s) is tested, handled, stored,
distributed and/or manufactured in accordance with this Agreement. 
 7.11.****. 

7.12. Change in Facility.   ****. 
  

	8.	INTELLECTUAL PROPERTY LICENSES 

 8.1. Licenses.   Customer hereby grants Flextronics a non-exclusive, non-transferable, non-sublicensable license during the term of this Agreement to use Customer’s patents,
trade secrets and other intellectual property solely as necessary to perform Flextronics’s obligations under this Agreement. 
 8.2. No Other Licenses.   Except as otherwise specifically provided in this Agreement, each party acknowledges and agrees that no licenses or rights under any of the intellectual
property rights of the other party are given or intended to be given to such other party. 
  

	9.	TERM AND TERMINATION 

9.1. Term.   The term of this Agreement shall commence on the Effective Date and shall continue in perpetuity
until terminated as provided in Section 9.2 (Termination) or 11.7 (Force Majeure). 
 9.2. Termination.
  This Agreement may be terminated by either party (a) for convenience upon one hundred eighty (180) days written notice to the other party, or (b) if the other party defaults in any payment to the terminating party and such
default continues without a cure for a period of fifteen (15) days after the delivery of written notice thereof by the terminating party to the other party, (c) if the other party defaults in the performance of any other material term or
condition of this Agreement and such default continues unremedied for a period of thirty (30) days after the delivery of written notice thereof by the terminating party to the other party, or (d) pursuant to Section 11.7 (Force Majeure).

 9.3. Effect of Termination.   Termination of this Agreement under any of the foregoing provisions
shall not affect (a) the amounts due under this Agreement by either party on or prior to the date of termination or (b) Flextronics’s express limited warranty in Section 6.2 above. As of the date of termination, the provisions of
Sections 5.2, 5.3 and 5.4 shall apply with respect to payment and shipment to Customer of finished Products, Inventory, and Special Inventory in existence as of such date. As directed by Customer, in Customer’s sole discretion, upon
termination, Flextronics shall return ship or dispose of tooling/software, equipment or property owned by the Customer. Termination of this Agreement and settling of accounts in the manner set forth in the foregoing sentence shall be the exclusive
remedy of the parties for breach of this Agreement, except for breaches of Section 6.2, 10.1, 10.2, or 11.1. Sections 1, 3.5, 3.6, 3.7, 3.8 4, 5.2, 5.3 5.4, 6.2, 6.3, 7.8, 9, 10, and 11 shall be the only terms that shall survive any termination
of this Agreement. 
  

	10.	INDEMNIFICATION; LIABILITY LIMITATION 

 10.1.            Indemnification by Flextronics.   Flextronics agrees to defend, indemnify and hold harmless Customer
and its Affiliates, and all of their respective directors, officers, employees, and agents (each, a “Customer Indemnitee”) from and against all claims, actions, losses, expenses, damages or other liabilities, including reasonable
attorneys’ fees (collectively, “Damages”) incurred by or assessed against any of the foregoing, but solely to the extent the same arise out of third-party claims relating to: 

(a)  any actual or threatened injury or damage to any person or property caused, or alleged to be caused, by a Product sold by
Flextronics to Customer hereunder, but solely to the extent such injury or damage has been caused by the breach by Flextronics of its express limited warranties related to Flextronics’s workmanship and manufacture in accordance with the
Specifications only as further set forth in Section 6.2; 
 (b)  any infringement of the intellectual property
rights of any third party, but solely to the extent that such infringement is caused by a process method or apparatus that Flextronics uses to manufacture, assemble and/or test the Products; provided that, Flextronics shall not have any obligation
to indemnify Customer if such claim would not have arisen but for Flextronics’s manufacture, assembly or test of the Product in accordance with the Specifications; or 
 (c)  noncompliance with any Environmental Regulations but solely to the extent that such non-compliance is caused by a process or Production Materials that Flextronics uses to manufacture the
Products; provided that, Flextronics shall not have any obligation to indemnify Customer if such claim would not have arisen but for Flextronics’s manufacture of the Product in accordance with the Specifications. 

  
  

**** Certain information on this page has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been
requested with respect to the omitted portions. 

10.2.            Indemnification by Customer. Customer agrees to
defend, indemnify and hold harmless, Flextronics and its Affiliates, and all directors, officers, employees and agents (each, a “Flextronics Indemnitee”) from and against all Damages incurred by or assessed against any of the
foregoing, but solely to the extent the same arise out of third-party claims relating to: 
 (a)  any failure of any
Product (and Materials contained therein) sold by Flextronics hereunder to comply with any safety standards and/or Environmental Regulations to the extent that such failure has not been caused by Flextronics’s breach of its express limited
warranties set forth in Section 6.2 hereof; 
 (b)  any actual or threatened injury or damage to any person or
property caused, or alleged to be caused, by a Product sold by Flextronics to Customer hereunder, but solely to the extent such injury or damage has not been caused by Flextronics’s breach of its express limited warranties related to
Flextronics’s workmanship and manufacture in accordance with the Specifications only as further set forth in Section 6.2 hereof; or 
 (c)  any infringement of the intellectual property rights of any third party by any Product except to the extent such infringement is the responsibility of Flextronics pursuant to
Section 10.1 (b) above. 

10.3.            Procedures for Indemnification.
  With respect to any third-party claims, either party shall give the other party prompt notice of any third-party claim. The failure to give such notice shall not relieve the indemnifying party from any liability that it may have to the
indemnified party under Article 9 except to the extent that the indemnifying party’s ability to defend such suit or claim is materially prejudiced by the failure to give such notice. The indemnifying party shall have the right to assume the
defense (at its own expense) of any such claim through counsel of its own choosing by so notifying the party seeking indemnification within thirty (30) calendar days of the first receipt of such notice, and the party seeking indemnification
shall cooperate fully with the indemnifying party in defense of such matter, at the indemnifying party’s expense. The party seeking indemnification shall have the right to participate in the defense thereof and to employ counsel, at its own
expense, separate from the counsel employed by the indemnifying party. The indemnifying party shall not, without the prior written consent of the indemnified party, agree to the settlement, compromise or discharge of such third-party claim, unless
such settlement, compromise or discharge includes an unconditional release of the party seeking indemnification from all liability on claims that are the subject matter of such proceeding and such settlement, compromise or discharge is exclusively
on financial terms which will be paid by the indemnifying party. If the indemnifying party does not assume control of the defense of such claims as provided in this Section 10.3, the indemnified party shall have the right to defend such claim
in such manner as it may deem appropriate at the cost and expense of the indemnifying party, and the indemnifying party shall promptly reimburse the indemnified party therefore in accordance with this Section 10.3. 

10.4.            Sale of Products Enjoined.   Should
the use of any Products be enjoined for a cause stated in Section 10.1(b) or 10.2(c) above, or in the event the indemnifying party desires to minimize its liabilities under this Section 10, in addition to its indemnification obligations
set forth in this Section 10, the indemnifying party’s responsibility is to either substitute a fully equivalent Product or process (as applicable) not subject to such injunction, modify such Product or process (as applicable) so that it
no longer is subject to such injunction, or obtain the right to continue using the enjoined process or Product (as applicable). In the event that any of the foregoing remedies cannot be effected on commercially reasonable terms, then all accepted
purchase orders and the current forecast will be considered cancelled and **** Customer shall purchase all Products, Inventory and Special Inventory as provided in Sections 5.3 and 5.4 hereof. Any changes to any Products or process must be made in
accordance with Sections 2.3 and 7.9 above. Notwithstanding the foregoing, in the event that a third party makes an infringement claim, but does not obtain an injunction, the indemnifying party shall not be required to substitute a fully equivalent
Product or process (as applicable) or modify the Product or process (as applicable) if the indemnifying party obtains an opinion from competent patent counsel reasonably acceptable to the other party that such Product or process is not infringing or
that the patents alleged to have been infringed are invalid. 

  
  

**** Certain information on this page has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been
requested with respect to the omitted portions. 

 10.5.            No
Other Liability.  IN NO EVENT SHALL EITHER PARTY BE LIABLE TO THE OTHER FOR ANY “COVER” DAMAGES (INCLUDING INTERNAL COVER DAMAGES WHICH THE PARTIES AGREE MAY NOT BE CONSIDERED “DIRECT” DAMAGES), OR ANY
INCIDENTAL, CONSEQUENTIAL, SPECIAL OR PUNITIVE DAMAGES OF ANY KIND OR NATURE ARISING OUT OF THIS AGREEMENT OR THE SALE OF PRODUCTS, WHETHER SUCH LIABILITY IS ASSERTED ON THE BASIS OF CONTRACT, TORT (INCLUDING THE POSSIBILITY OF NEGLIGENCE OR STRICT
LIABILITY), OR OTHERWISE, EVEN IF THE PARTY HAS BEEN WARNED OF THE POSSIBILITY OF ANY SUCH LOSS OR DAMAGE, AND EVEN IF ANY OF THE LIMITED REMEDIES IN THIS AGREEMENT FAIL OF THEIR ESSENTIAL PURPOSE. THE FOREGOING SENTENCE SHALL NOT LIMIT THE
OBLIGATIONS OF EITHER PARTY TO INDEMNIFY THE OTHER PARTY FROM AND AGAINST THIRD-PARTY CLAIMS UNDER SECTION 10 OR LIABILITIES RESULTING FROM A BREACH OF THE CONFIDENTIALITY OBLIGATIONS UNDER SECTION 11.1. 

THE FOREGOING SECTION 10 STATES THE ENTIRE LIABILITY OF THE PARTIES TO EACH OTHER CONCERNING INFRINGEMENT OF PATENT, COPYRIGHT, TRADE
SECRET OR OTHER INTELLECTUAL PROPERTY RIGHTS. 
  

	11.	MISCELLANEOUS 

11.1.            Confidentiality. 

(a)  Nondisclosure and Nonuse Obligations. Recipient shall refrain from using any and all Confidential Information of the
Discloser for any purposes or activities other than those specifically authorized in this Agreement. Except as otherwise specifically permitted herein or pursuant to written permission of the Discloser, Recipient shall disclose Discloser’s
Confidential Information only to those of Recipient’s employees, consultants, Affiliates, and contractors who need to know such information. Recipient certifies that each such employee, consultant, Affiliate and contractor will have agreed,
either as a condition to employment or in order to obtain Discloser’s Confidential Information, to be bound by terms and conditions substantially similar to those terms and conditions applicable to Recipient under this Agreement. Recipient
shall treat all of Discloser’s Confidential Information with the same degree of care as Recipient accords to Recipient’s own Confidential Information, but not less than reasonable care. Recipient shall immediately give notice to Discloser
of any unauthorized use or disclosure of Discloser’s Confidential Information. Recipient shall assist Discloser in remedying any such unauthorized use or disclosure of Discloser’s Confidential Information. In addition, Recipient shall not
undertake, nor assist any third party in undertaking, any efforts to reverse engineer, disassemble, decompile or ascertain the structure, method of operation or method of manufacture, of any Products, prototypes, software, samples or other tangible
objects or materials which embody Discloser’s Confidential Information and which are provided to Recipient hereunder. The existence and terms of this Agreement shall be the Confidential Information of both parties. 

(b)  Exclusions from Nondisclosure and Nonuse Obligations. 

 

	 	(i)	Confidential Information does not include information that (A) Recipient can prove it already knew at the time of receipt from Discloser; (B) has come into
the public domain without breach of confidence by Recipient; (C) was received by Recipient from a third party without restrictions on its use; (D) Recipient can prove it independently developed without use of or reference to
Discloser’s data or information; or (E) Discloser agrees in writing is free of such restrictions. 

  

	 	(ii)	Notwithstanding Section 11.1(a), Recipient may disclose Discloser’s Confidential Information pursuant to a subpoena or other court process or as otherwise
required by law; provided that Recipient (A) gives Discloser prompt notice of Recipient’s receipt of such subpoena or other process or the legal requirement to disclose in advance such that Discloser has opportunity to contest,
(B) uses commercially reasonable efforts to obtain confidential treatment of financial and trade secret information and, (C) if reasonably practicable under the circumstances, gives Discloser a reasonable opportunity to oppose such
subpoena or other process or to obtain a protective order or other remedy. 

	 	(iii)	Ownership and Return of Confidential Information and Other Materials. All of Discloser’s Confidential Information, and any Derivatives (defined below) thereof,
whether created by such Discloser or Recipient, are the property of Discloser and no license or other rights to such Discloser’s Confidential Information or Derivatives is granted or implied hereby. For purposes of this Agreement,
“Derivatives” shall mean: (i) for copyrightable or copyrighted material, any translation, abridgment, revision or other form in which an existing work may be recast, transformed or adapted; (ii) for patentable or patented
material, any improvement thereon; and (iii) for material that is protected by trade secret, any new material derived from such existing trade secret material, including new material which may be protected under copyright, patent and/or trade
secret laws. All materials (including, without limitation, documents, drawings, papers, diskettes, tapes, models, apparatus, sketches, designs and lists) furnished by Discloser to Recipient (whether or not they contain or disclose Discloser’s
Confidential Information) are the property of such Discloser. Within five (5) days after any request by Discloser, Recipient shall destroy or deliver to Discloser, at Discloser’s option, (x) all such Discloser-furnished materials and
(y) all materials in Recipient’s possession or control (even if not Discloser-furnished) that contain or disclose any of such Discloser’s Confidential Information, except copies retained on backup tapes which cannot be destroyed, for
which the duty of confidentiality pursuant to this Section 11.1 shall continue for so long as such tapes exist. Recipient will provide Discloser a written certification of Recipient’s compliance with Recipient’s obligations under this
Section. 

  

	 	(iv)	Independent Development. Recipient may currently or in the future be developing information internally, or receiving information from other parties, that may be similar
to such Discloser’s Confidential Information. Accordingly, nothing in this Agreement shall be construed as a representation or inference that Recipient will not develop or have developed products or services that, without violation of this
Agreement, might compete with the products or systems contemplated by such Discloser’s Confidential Information. 

  

	 	(v)	Disclosure of Third Party Information. Neither party shall communicate any information to the other in violation of the proprietary rights of any third party.

  

	 	(vi)	No Warranty. All Confidential Information is provided by Discloser “AS IS- and without any warranty, express, implied or otherwise, regarding such Confidential
Information’s accuracy or performance. 

  

	 	(vii)	No Export. Recipient will obtain any licenses or approvals the U.S. government or any agency thereof requires prior to exporting, directly or indirectly, any technical
data acquired from Discloser pursuant to this Agreement or any product utilizing any such data (to the extent such activities are otherwise permitted by this Agreement). 

 

	 	(viii)	Injunctive Relief. A breach by Recipient of this Section 11.1 will cause irreparable and continuing damage to Discloser for which money damages are insufficient,
and Discloser shall be entitled to seek injunctive relief and/or a decree for specific performance, and such other relief as may be proper (including money damages if appropriate). 

(c)  Use of Names.   No right, expressed or implied, is granted by this Agreement to a party to use in
any manner the name or any other trade name or identity of the other party or its Affiliates in connection with this Agreement. Notwithstanding the foregoing, Customer shall have the right to use the Flextronics name on package inserts or packaging
associated with the Product solely as required by applicable laws. 
 (d)  Term of Confidentiality.
  The obligations of the Recipient with respect to the Confidential Information shall, unless specifically released earlier by the disclosing party in writing, extend for a period of five (5) years from the date on which such Confidential
Information is disclosed. 

 11.2.            Entire
Agreement; Severability.   This Agreement constitutes the entire agreement between the Parties with respect to the transactions contemplated hereby and supersedes all prior agreements and understandings between the parties relating
to such transactions ****. All Confidential Information disclosed by either party to the other party prior to the Effective Date will be deemed to have been disclosed pursuant to this Agreement. If the scope of any of the provisions of this
Agreement is too broad in any respect whatsoever to permit enforcement to its full extent, then such provisions shall be enforced to the maximum extent permitted by law, and the parties hereto consent and agree that such scope may be judicially
modified accordingly and that the whole of such provisions of this Agreement shall not thereby fail, but that the scope of such provisions shall be curtailed only to the extent necessary to conform to law. 

11.3.            Amendments; Waiver.   This Agreement
may be amended only by written consent of both parties. The failure by either party to enforce any provision of this Agreement will not constitute a waiver of future enforcement of that or any other provision. Neither party will be deemed to have
waived any rights or remedies hereunder unless such waiver is in writing and signed by a duly authorized representative of the party against which such waiver is asserted. 
 11.4.            Independent Contractor.   Neither party shall, for any purpose, be deemed to be an agent of the other
party and the relationship between the parties shall only be that of independent contractors. Neither party shall have any right or authority to assume or create any obligations or to make any representations or warranties on behalf of the
other party, whether express or implied, or to bind the other party in any respect whatsoever. 

11.5.            Expenses.   Each party shall pay
their own expenses in connection with the negotiation of this Agreement. All fees and expenses incurred in connection with the resolution of Disputes shall be allocated as further provided in Section 11.10 below. 

11.6.            Insurance.   Flextronics and Customer
agree to maintain appropriate insurance to cover their respective risks under this Agreement with coverage amounts commensurate with levels in their respective markets. Customer specifically agrees to maintain insurance coverage for any finished
Products or Materials the title and risk of loss of which passes to Customer pursuant to this Agreement and which is stored on the premises of Flextronics. 
 11.7.            Force Majeure.   In the event that either party is prevented from performing or is unable to perform
any of its obligations under this Agreement (other than a payment obligation) due to any act of God, acts or decrees of governmental or military bodies, fire, casualty, flood, earthquake, war, strike, lockout, epidemic, destruction of production
facilities, riot, insurrection, Materials unavailability, or any other cause beyond the reasonable control of the party invoking this section (collectively, a “Force Majeure”), and if such party shall have used its commercially
reasonable efforts to mitigate its effects, such party shall give prompt written notice to the other party, its performance shall be excused, and the time for the performance shall be extended for the period of delay or inability to perform due to
such occurrences. Regardless of the excuse of Force Majeure, if such party is not able to perform within ninety (90) days after such event, the other party may terminate the Agreement. 

11.8.            Successors Assignment.   This
Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective successors, assigns and legal representatives. Neither party shall have the right to assign or otherwise transfer its rights or obligations under
this Agreement except with the prior written consent of the other party, not to be unreasonably withheld or delayed. Notwithstanding the foregoing, Flextronics may assign some or all of its rights and obligations under this Agreement to an Affiliate
of Flextronics that is wholly-owned by Flextronics ****. In addition, either party may assign its rights and obligations under this Agreement to its successor in connection with a Change of Control, without the other party’s consent, provided
that (a) such successor agrees in writing to be bound by the terms and conditions of this Agreement and (b) in the case of an assignment by Customer, such successor is not a competitor of Flextronics that generates revenue primarily from
the contract manufacturing of electronic products for third parties and (c) in the case of an assignment by Customer, Flextronics’ prior written consent shall be required based upon the financial profile of the successor, such consent not
to be unreasonably withheld. 

11.9.            Notices.   All notices required or
permitted under this Agreement will be in writing and will be deemed received (a) when delivered personally; (b) when sent by confirmed facsimile; (c) five (5) days after having been sent by registered or certified mail, return
receipt requested, postage prepaid; or (d) one (1) day after deposit with a commercial overnight carrier. All communications will be sent to the addresses set forth above or to such other address as may be designated by a party by giving
written notice to the other party pursuant to this section. 

  
  

**** Certain information on this page has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been
requested with respect to the omitted portions. 

 11.10.            Disputes
Resolution; Waiver of Jury Trial. 
 (a)  Except as otherwise provided in this Agreement, the following binding
dispute resolution procedures shall be the exclusive means used by the parties to resolve all disputes, differences, controversies and claims arising out of or relating to the Agreement or any other aspect of the relationship between Flextronics and
Customer or their respective Affiliates and subsidiaries (collectively, “Disputes”). Either party may, by written notice to the other party, refer any Disputes for resolution in the manner set forth below. 

(b)  Any and all Disputes shall be referred to arbitration under the rules and procedures of the American Arbitration
Association, Inc. (“AAA”), who shall act as the arbitration administrator (the “Arbitration Administrator”). 
 (c)  The parties shall agree on a single arbitrator (the “Arbitrator”). The Arbitrator shall be a retired judge selected by the parties from a roster of arbitrators provided by
the Arbitration Administrator. If the parties cannot agree on an Arbitrator within seven (7) days of delivery of the demand for arbitration (“Demand”) (or such other time period as the parties may agree), the Arbitration
Administrator will select an independent Arbitrator. 
 (d)  Unless otherwise mutually agreed to by the parties, the
place of arbitration shall be New York, New York, although the arbitrators may be selected from rosters outside New York. 

(e)  The Federal Arbitration Act shall govern the arbitrability of all Disputes. The Federal Rules of Civil Procedure and the
Federal Rules of Evidence (the “Federal Rules”), to the extent not inconsistent with this Agreement, shall govern the conduct of the arbitration. To the extent that the Federal Arbitration Act and Federal Rules do not provide an
applicable procedure, New York law shall govern the procedures for arbitration and enforcement of an award, and then only to the extent not inconsistent with the terms of this Section. Disputes between the parties shall be subject to arbitration
notwithstanding that a party to this Agreement is also a party to a pending court action or special proceeding with a third party, arising out of the same transaction or series of related transactions and there is a possibility of conflicting
rulings on a common issue of law or fact. 
 (f)  Unless otherwise mutually agreed to by the parties, each party shall
allow and participate in discovery as follows: 
 (i)          Non-Expert
Discovery.  Each party may (1) conduct three (3) non-expert depositions of no more than five (5) hours of testimony each, with any deponents employed by any party to appear for deposition in New York, New York;
(2) propound a single set of requests for production of documents containing no more than twenty (20) individual requests; (3) propound up to twenty written interrogatories; and (4) propound up to ten (10) requests for
admission. 
 (ii)          Expert Discovery.  Each party may
select a witness who is retained or specially employed to provide expert testimony and an additional expert witness to testify with respect to damages issues, if any. The parties shall exchange expert reports and documents under the same
requirements as Federal Rules of Civil Procedure 26(a)(2) &(4). 

(iii)          Additional Discovery.  The Arbitrator may, on
application by either party, authorize additional discovery only if deemed essential to avoid injustice. In the event that remote witnesses might otherwise be unable to attend the arbitration, arrangements shall be made to allow their live testimony
by video conference during the arbitration hearing. 
 (g)  The Arbitrator shall render an award within six
(6) months after the date of appointment, unless the parties agree to extend such time. The award shall be accompanied by a written opinion setting forth the findings of fact and conclusions of law. The Arbitrator shall have authority to award
compensatory damages only, and shall not award any punitive, exemplary, or multiple damages. The award (subject to clarification or correction by the arbitrator as allowed by statute and/or the Federal Rules) shall be final and binding upon the
parties, subject solely to the review procedures provided in this Section. 
 (h)  Either party may seek arbitral
review of the award. Arbitral review may be had as to any element of the award. 
 (i)  This Agreement’s
arbitration provisions are to be performed in New York, New York. Any judicial proceeding arising out of or relating to this Agreement or the relationship of the parties, including without limitation any proceeding to enforce this Section, to review
or confirm the award in arbitration, or for preliminary injunctive relief, shall be brought exclusively in a court of competent jurisdiction in the county of New York, New York (the “Enforcing Court”). By execution and delivery of
this Agreement, each party accepts the jurisdiction of the Enforcing Court. 
 (j)  Each party shall pay their own
expenses in connection with the resolution of Disputes pursuant to this Section, including attorneys’ fees. 

(k)  Notwithstanding anything contained in this Section to the contrary, in the event of any Dispute, prior to referring such
Dispute to arbitration pursuant to Subsection (b) of this Section, Customer and Flextronics shall attempt in good faith to resolve any and all controversies or claims relating to such Disputes promptly by negotiation commencing within ten
(10)

 
calendar days of the written notice of such Disputes by either party, including referring such matter to Customer’s then-current President and Flextronics’s then current executive in
charge of manufacturing operations in the region in which the primary activities of this Agreement are performed by Flextronics. The representatives of the parties shall meet at a mutually acceptable time and place and thereafter as often as they
reasonably deem necessary to exchange relevant information and to attempt to resolve the Dispute for a period of four (4) weeks. In the event that the parties are unable to resolve such Dispute pursuant to this Subsection (k), the provisions of
Subsections (a) through (j) of this Section, inclusive, as well as Subsections (1), (m) and (n) of this Section shall apply. 
 (l)  The parties agree that the existence, conduct and content of any arbitration pursuant to this Section shall be kept confidential and no party shall disclose to any person any information
about such arbitration, except as may be required by law or by any governmental authority or for financial reporting purposes in each party’s financial statements. 
 (m)  IN THE EVENT OF ANY DISPUTE BETWEEN THE PARTIES, WHETHER IT RESULTS IN PROCEEDINGS IN ANY COURT IN ANY JURISDICTION OR IN ARBITRATION, THE PARTIES HEREBY KNOWINGLY AND VOLUNTARILY, AND
HAVING HAD AN OPPORTUNITY TO CONSULT WITH COUNSEL, WAIVE ALL RIGHTS TO TRIAL BY JURY, AND AGREE THAT ANY AND ALL MATTERS SHALL BE DECIDED BY A JUDGE OR ARBITRATOR WITHOUT A JURY TO THE FULLEST EXTENT PERMISSIBLE UNDER APPLICABLE LAW. 

(n)  In the event of any lawsuit between the parties arising out of or related to this Agreement, the parties agree to prepare
and to timely file in the applicable court a mutual consent to waive any statutory or other requirements for a trial by jury. 

(o)  Customer Guaranty. Customer hereby unconditionally guarantees to Flextronics the full and prompt compliance
by all Customer Affiliates with the terms and conditions of this Agreement, whether now existing or later arising (the “Guaranteed Obligations”). This guarantee is absolute, continuing, unlimited and independent and will not be
affected, diminished or released for any reason. Customer waives (i) diligence, presentment, demand for payment, protest or notice of any default or nonperformance by any Customer Affiliate, (ii) notice of waivers or indulgences given to
any Customer Affiliate and (iii) all defenses, offsets and counterclaims against Flextronics, any right to the benefit of any security or statute of limitations, and any requirement that Flextronics proceed first against a Customer Affiliate or
any collateral security and all other suretyship defenses. Until the Guaranteed Obligations have been paid and performed in full, Customer will not enforce any right of subrogation. Customer shall indemnify, defend and hold Flextronics and its
Affiliates harmless from any and all claims by any Customer Affiliates to the extent that such claims are inconsistent with the terms and conditions of this Agreement. For purposes of this Section 11.10, “Customer Affiliates”
means Affiliates of Customer who purchase Products from Flextronics or any of its Affiliates under this Agreement. 

11.11.            Even-Handed Construction. The terms and
conditions as set forth in this Agreement have been arrived at after mutual negotiation, and it is the intention of the parties that its terms and conditions not be construed against any party merely because it was prepared by one of the parties.

 11.12.            Controlling Language. This
Agreement is in English only, which language shall be controlling in all respects. All documents exchanged under this Agreement shall be in English. 
 11.13.            Controlling Law. This Agreement shall be governed and construed in all respects in accordance with the domestic
laws and regulations of the State of New York, without regard to its conflicts of laws provisions; except to the extent there may be any conflict between the law of the State of New York and the Incoterms of the International Chamber of Commerce,
2000 edition, in which case the Incoterms shall be controlling. The parties specifically agree that the 1980 United Nations Convention on Contracts for the International Sale of Goods, as may be amended from time to time, shall not apply to this
Agreement. The parties acknowledge and confirm that they have selected the laws of the State of New York as the governing law for this Agreement in part because jury trial waivers are enforceable under New York law. The parties further acknowledge
and confirm that the selection of the governing law is a material term of this Agreement. 

11.14.            Heading. Headings in this Agreement are
included herein for ease of reference only and shall have no legal effect. References to the parties, Sections, Schedules, and Exhibits are to the parties, Sections, Schedules and Exhibits to and of this Agreement unless otherwise specified.

 11.15.            Counterparts. This Agreement may
be executed in counterparts, each of which, when executed, shall be deemed to be an original and which together shall constitute one and the same document. 

 IN WITNESS WHEREOF, the parties have caused this Agreement to be duly executed by their duly authorized
representatives as of the Effective Date. 
  

									
	TRIA BEAUTY, INC.	 		 	FLEXTRONICS MEDICAL SALES AND MARKETING,
LTD.
					
	By:	 	 /s/Suresh Vilayanur 9/21/2010
	 		 	By:	 	 /s/ Manny Marimuthu

					
	Name:	 	Suresh Vilayanur	 		 	Name:	 	Manny Marimuthu
					
	Title:	 	VP of Product Supply	 		 	Title:	 	 Director

					
	 	  	   List of Exhibits
	  	 
	Exhibit 1	  	List of Definitions	  	
	Exhibit 2.1	  	Specifications	  	
	Exhibit 3.4a	  	**** Fees	  	
	Exhibit 4.1a	  	**** Supply Review Overview	  	
	Exhibit 4.1b	  	List of documents to be discussed at MSR	  	
	Exhibit 4.1c	  	Material Supply Sheet	  	

  
  

**** Certain information on this page has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been
requested with respect to the omitted portions. 

 Exhibit 1 
 Definitions 
  

			
	 “Affected Inventory Costs
  

 
  
  

 
 “Affiliate”
	 	 shall mean as related to reschedule or cancellation (as applicable): (i) **** of the Cost of all affected Inventory and Special
Inventory in Flextronics’s possession and not returnable to the vendor or reasonably usable for other customers, whether in raw form or work in process, less the salvage value thereof, (ii) **** of the Cost of all affected Inventory and Special
Inventory on order and not cancelable, (iii) any vendor cancellation charges incurred with respect to the affected Inventory and Special Inventory accepted for cancellation or return by the vendor, (iv) the then current fees for any affected
finished Product, and (v) reasonable expenses incurred by Flextronics related to labor and equipment specifically put in place to support the purchase orders and forecasts that are affected by such reschedule or cancellation (as
applicable).
  
 shall mean: any party that directly (or indirectly through
one or more intermediaries) controls, is controlled by, or is under common control with a party. For purposes of this definition only, the terms “controls,” “controlled,” and “control” means (a) the direct or indirect
ability or power to direct or cause the direction of the management and policies of an entity or otherwise direct the affairs of such entity, whether through ownership of equity, voting securities, or beneficial interest, by contract, or otherwise,
or (b) the ownership, directly or indirectly, of at least 50% of the voting securities (or other comparable ownership interest for an entity other than a corporation) of a party.

		
	“Approved Supplier List” or “ASL”	 	shall mean the list of suppliers currently approved to provide the Materials specified in the bill of materials for a Product.
		
	“Change of Control”	 	shall mean, with respect to a party, (a) a merger or consolidation of such party with a third party which results in the voting securities of such party outstanding immediately
prior thereto ceasing to represent at least fifty percent (50%) of the combined voting power of the surviving entity immediately after such merger or consolidation, or (b) except in the case of a bona fide equity financing in which a party issues
new shares of its capital stock, a transaction or series of related transactions in which a third party, together with its Affiliates, becomes the beneficial owner of fifty percent (50%) or more of the combined voting power of the outstanding
securities of such party, or (c) the sale or other transfer to a third party of all or substantially all of such party’s business to which the subject matter of this Agreement relates.
		
	“Confidential Information”	 	shall mean (a) any technical and non-technical information related to a party’s business and current, future and proposed products and services of each of the parties,
including for example and without limitation, each party’s respective information concerning, manufacturing processes, research, development, design details and specifications, financial information, procurement requirements, engineering and
manufacturing information, customer lists, business forecasts, sales information and marketing

  
  

**** Certain information on this page has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been
requested with respect to the omitted portions. 

			
		 	plans and (b) any information a party has received from others that may be made known to the other party and which such party is obligated to treat as confidential or proprietary,
in each case in written, electronic, oral or other form; provided, however, that any such information disclosed by a party to this Agreement (“Discloser”) will only be considered Confidential Information of Discloser by the other party
(“Recipient”) (i) if marked as “Confidential” or “Proprietary” or using a similar designation, in the case of information disclosed in written, electronic or other tangible form, and (ii) if identified as confidential
at the time of disclosure and also summarized and designated as confidential in a written memorandum delivered to Recipient within thirty (30) days of the disclosure, in the case of information disclosed in any other manner. ****.
		
	“Cost”	 	shall mean the cost represented on the bill of materials supporting the most current fees for Products at the time of cancellation, or termination, as applicable.
		
	 “Cost of Direct Labor”
	 	shall mean, with respect to any Product, the product of (a) the number of hours of operating time spent by Flextronics’s production employees to convert Materials into a
finished Product and (b) the hourly pay of each such employee. For the sake of clarity, all other employee costs (i.e., employee benefits, overtime premiums or shift premiums) are not included as part of the Cost of Direct Labor.
		
	 “Cost of Materials”
	 	shall mean, with respect to any Product, the weighted average of actual costs paid by Flextronics to third party vendors to acquire Materials. For the sake of clarity, the Cost of
Direct Labor, warehousing, overhead, and research and development are not included as part of Cost of Materials.
		
	Customer Affiliates	 	
		
	“Customer Controlled Materials”	 	shall mean those Materials provided by Customer or by suppliers with whom Customer has a commercial contractual or non-contractual relationship to supply those
materials.
		
	 “Customer Controlled Materials
  

Terms”
	 	shall mean the terms and conditions that Customer has negotiated with its suppliers for the purchase of Customer Controlled Materials.
		
	“Customer Indemnitees”	 	shall have the meaning set forth in Section 10.1.
		
	“Device History Record”	 	shall mean a compilation of records containing the production history of the Product(s).
		
	“Device Master Record”	 	shall mean a compilation of records containing the procedures and Specifications for the Product.
		
	“Discloser”	 	shall have the meaning set forth in the definition of “Confidential Information”.
		
	“Damages”	 	shall have the meaning set forth in Section10.1.
		
	“Disputes”	 	shall have the meaning set forth in Section 11.10(a).
		
	“E&O Inventory”	 	shall mean Inventory that is excess and obsolete because there is no MRP Demand for such Inventory over the forecast period.
		
	“Economic Order Inventory”	 	shall mean Materials purchased in quantities above the required amount for purchase orders, in order to achieve price targets for such Materials.
		
	“Environmental Regulations”	 	shall mean any hazardous substance content laws and regulations including, without limitation, those related to the EU Directive 2002/95/EC about the Restriction of Use of Hazardous
Substances (RoHS).

  
  

**** Certain information on this page has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been
requested with respect to the omitted portions. 

			
	****	 	****
		
	“FDA”	 	shall mean the United States Food and Drug Administration, and any successor agency having substantially the same functions.
		
	“Fee List”	 	shall have the meaning set forth in Section 3.4.
		
	“Flexibility Table”	 	shall have the meaning set forth in Section 5.2(a).
		
	“Flextronics Indemnitee”	 	shall have the meaning set forth in Section 10.2.
		
	“Force Majeure”	 	shall have the meaning set forth in Section 11.7.
		
	“Inventory”	 	shall mean any Materials ordered or held available in stock by Flextronics that are used to manufacture Products that are ordered pursuant to a purchase order from
Customer..
		
	“Lead Time(s)”	 	shall mean the Materials Procurement Lead Time plus the manufacturing cycle time required from the delivery of the Materials at Flextronics’s facility to the completion of the
manufacture, assembly and test processes as agreed upon at the **** MSR.
		
	“Long Lead Time Materials”	 	shall mean Materials with a Materials Procurement Lead time greater than ****.
		
	“Materials”	 	shall mean components, parts and subassemblies that comprise the Products and that appear on the bill of materials for the Products.
		
	“Materials Procurement Lead Time”	 	shall mean with respect to any particular item of Materials, the longer of (a) lead time to obtain such Materials as recorded on Flextronics’s MRP Demand system, which shall be
the agreed upon lead times presented at the MSR or (b) the actual lead time, if a supplier has increased the lead time and such has been agreed to at the MSR
		
	“Minimum Order Inventory”	 	shall mean Materials purchased in excess of requirements for purchase orders because of minimum lot sizes available from the supplier.
		
	“Monthly Charges”	 	shall mean a finance carrying charge of **** and a storage and handling charge of ****, in each case of the Cost of the Inventory and/or Special Inventory and/or of the fees for the
Product affected by the reschedule or cancellation (as applicable) per month until such Inventory and/or Special Inventory and/or Product is returned to the vendor, used to manufacture Product or is otherwise purchased by Customer.
		
	MRP Demand”	 	shall mean materials requirements planning in accordance with Customer’s forecasts and accepted purchase orders.
		
	“NCNR”	 	Non cancellable and non-returnable with defined cancellation window

  
  

**** Certain information on this page has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been
requested with respect to the omitted portions. 

			
	“Production Materials”	 	shall mean Materials that are consumed in the production processes to manufacture Products including, without limitation, solder, epoxy, cleaner solvent, labels, flux, and glue.
Production Materials do not include any such production materials that have been specified by the Customer or any Customer Controlled Materials.
		
	“QSR”	 	shall mean Quality System Regulation which describe the regulatory requirements for the methods used in and the facilities and controls used for, the design, manufacture, packing,
labeling, storage, installation and servicing of finished devices, codified at 21, Code of US Federal Regulations, Part 820, as may be amended from time to time.
		
	“Recipient”	 	shall have the meaning set forth in the definition of “Confidential Information”.
		
	“Special Inventory”	 	shall mean any Long Lead Time Materials and/or Minimum Order Inventory and/or Economic Order Inventory.
		
	“Specifications”	 	shall have the meaning set forth in Section 2.1.
		
	“Work”	 	shall have the meaning set forth in Section 2.1.

 Exhibit 2.1 
 Specifications 
 EXHIBIT 3.4a- Hair Generation 2.1 

**** 
 ****

  
  

**** Certain information on this page has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been
requested with respect to the omitted portions. 

 Exhibit 4.1 
 MSR OVERVIEW 
 **** 

  
  

**** Certain information on this page has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been
requested with respect to the omitted portions. 

 Exhibit 4.1(b) 
 List of documents to be Reviewed at MSR 
 **** 

  
  

**** Certain information on this page has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been
requested with respect to the omitted portions. 

 Exhibit 4.1(c) 
 MATERIAL SUPPLY SHEET 
 **** 

  
  

**** Certain information on this page has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been
requested with respect to the omitted portions.2004 Stock Incentive Plan

 Exhibit 10.3 
 TRIA BEAUTY, INC. 
 2004 STOCK PLAN 

(as amended November 12, 2008) 
 1. ESTABLISHMENT, PURPOSE AND TERM OF PLAN. 

1.1 Establishment. TRIA Beauty, Inc. 2004 Stock Plan (the “Plan”) is hereby
established effective as of January 15, 2004. 
 1.2 Purpose. The purpose of the Plan is to advance
the interests of the Participating Company Group and its shareholders by providing an incentive to attract, retain and reward persons performing services for the Participating Company Group and by motivating such persons to contribute to the growth
and profitability of the Participating Company Group. 
 1.3 Term of Plan. The Plan shall continue in effect until the
earlier of its termination by the Board or the date on which all of the shares of Stock available for issuance under the Plan have been issued and all restrictions on such shares under the terms of the Plan and the agreements evidencing Awards
granted under the Plan have lapsed. However, all Awards shall be granted, if at all, within ten (10) years from the earlier of the date the Plan is adopted by the Board or the date the Plan is duly approved by the shareholders of the Company.

 2. DEFINITIONS AND CONSTRUCTION. 

2.1 Definitions. Whenever used herein, the following terms shall have their respective meanings set forth below: 

(a) “Award” means an Option or Stock Purchase Right granted under the Plan. 

(b) “Board” means the Board of Directors of the Company. If one or more Committees have been
appointed by the Board to administer the Plan, “Board” also means such Committee(s). 

(c) “Code” means the Internal Revenue Code of 1986, as amended, and any applicable regulations
promulgated thereunder. 
 (d) “Committee” means the compensation committee or other
committee of the Board duly appointed to administer the Plan and having such powers as shall be specified by the Board. Unless the powers of the Committee have been specifically limited, the Committee shall have all of the powers of the Board
granted herein, including, without limitation, the power to amend or terminate the Plan at any time, subject to the terms of the Plan and any applicable limitations imposed by law. 

(e) “Company” means TRIA Beauty, Inc. (formerly named SpectraGenics, Inc.), a California
corporation, or any successor corporation thereto. 

  
 1 

 (f) “Consultant” means a person engaged to provide
consulting or advisory services (other than as an Employee or a Director) to a Participating Company, provided that the identity of such person, the nature of such services or the entity to which such services are provided would not preclude the
Company from offering or selling securities to such person pursuant to the Plan in reliance on either the exemption from registration provided by Rule 701 under the Securities Act or, if the Company is required to file reports pursuant to
Section 13 or 15(d) of the Exchange Act, registration on a Form S-8 Registration Statement under the Securities Act. 

(g) “Director” means a member of the Board or of the board of directors of any other Participating
Company. 
 (h) “Disability” means the inability of the Participant, in the opinion of a
qualified physician acceptable to the Company, to perform the major duties of the Participant’s position with the Participating Company Group because of the sickness or injury of the Participant. 

(i) “Employee” means any person treated as an employee (including an Officer or a Director who is
also treated as an employee) in the records of a Participating Company and, with respect to any Incentive Stock Option granted to such person, who is an employee for purposes of Section 422 of the Code; provided, however, that neither service
as a Director nor payment of a director’s fee shall be sufficient to constitute employment for purposes of the Plan. The Company shall determine in good faith and in the exercise of its discretion whether an individual has become or has ceased
to be an Employee and the effective date of such individual’s employment or termination of employment, as the case may be. For purposes of an individual’s rights, if any, under the Plan as of the time of the Company’s determination,
all such determinations by the Company shall be final, binding and conclusive, notwithstanding that the Company or any court of law or governmental agency subsequently makes a contrary determination. 

(j) “Exchange Act” means the Securities Exchange Act of 1934, as amended. 

(k) “Fair Market Value” means, as of any date, the value of a share of Stock or other property as
determined by the Board, in its discretion, or by the Company, in its discretion, if such determination is expressly allocated to the Company herein, subject to the following: 

(i) If, on such date, the Stock is listed on a national or regional securities exchange or market system, the Fair Market Value of a
share of Stock shall be the closing price of a share of Stock (or the mean of the closing bid and asked prices of a share of Stock if the Stock is so quoted instead) as quoted on the Nasdaq National Market, The Nasdaq SmallCap Market or such other
national or regional securities exchange or market system constituting the primary market for the Stock, as reported in The Wall Street Journal or such other source as the Company deems reliable. If the relevant date does not fall on a day on
which the Stock has traded on such securities exchange or market system, the date on which the Fair Market Value shall be established shall be the last day on which the Stock was so traded prior to the relevant date, or such other appropriate day as
shall be determined by the Board, in its discretion. 

  
 2 

 (ii) If, on such date, the Stock is not listed on a national or regional securities
exchange or market system, the Fair Market Value of a share of Stock shall be as determined by the Board in good faith and consistent with the applicable requirements of Sections 409A and 422 of the Code. 

(l) “Incentive Stock Option” means an Option intended to be (as set forth in the Option Agreement)
and which qualifies as an incentive stock option within the meaning of Section 422(b) of the Code. 
 (m)
“Insider” means an Officer, a Director of the Company or other person whose transactions in Stock are subject to Section 16 of the Exchange Act. 

(n) “Nonstatutory Stock Option” means an Option not intended to be (as set forth in the Option
Agreement) or which does not qualify as an Incentive Stock Option. 
 (o) “Officer” means
any person designated by the Board as an officer of the Company. 
 (p) “Option” means a
right granted under Section 6 to purchase Stock pursuant to the terms and conditions of the Plan. An Option may be either an Incentive Stock Option or a Nonstatutory Stock Option. 

(q) “Option Agreement” means a written agreement between the Company and a Participant setting
forth the terms, conditions and restrictions of the Option granted to the Participant and any shares acquired upon the exercise thereof. An Option Agreement may consist of a form of “Notice of Grant of Stock Option” and a form of
“Stock Option Agreement” incorporated therein by reference, or such other form or forms as the Board may approve from time to time. 
 (r) “Parent Corporation” means any present or future “parent corporation” of the Company, as defined in Section 424(e) of the Code. 

(s) “Participant” means any eligible person who has been granted one or more Awards. 

(t) “Participating Company” means the Company or any Parent Corporation or Subsidiary Corporation.

 (u) “Participating Company Group” means, at any point in time, all corporations
collectively which are then Participating Companies. 
 (v) “Rule 16b-3” means
Rule 16b-3 under the Exchange Act, as amended from time to time, or any successor rule or regulation. 
 (w)
“Securities Act” means the Securities Act of 1933, as amended. 

  
 3 

 (x) “Service” means a Participant’s employment
or service with the Participating Company Group, whether in the capacity of an Employee, a Director or a Consultant. A Participant’s Service shall not be deemed to have terminated merely because of a change in the capacity in which the
Participant renders Service to the Participating Company Group or a change in the Participating Company for which the Participant renders such Service, provided that there is no interruption or termination of the Participant’s Service.
Furthermore, a Participant’s Service shall not be deemed to have terminated if the Participant takes any military leave, sick leave, or other bona fide leave of absence approved by the Company; provided, however, that if any such leave exceeds
ninety (90) days, on the one hundred eighty-first (181st) day following the commencement of such leave any Incentive Stock Option held by the Participant shall cease to be treated as an Incentive Stock Option and instead shall be treated
thereafter as a Nonstatutory Stock Option unless the Participant’s right to return to Service is guaranteed by statute or contract. Notwithstanding the foregoing, unless otherwise designated by the Company or required by law, a leave of absence
shall not be treated as Service for purposes of determining vesting under the Participant’s Option Agreement or Stock Purchase Agreement. Except as otherwise provided by the Board, in its discretion, the Participant’s Service shall be
deemed to have terminated either upon an actual termination of Service or upon the corporation for which the Participant performs Service ceasing to be a Participating Company. Subject to the foregoing, the Company, in its discretion, shall
determine whether the Participant’s Service has terminated and the effective date of and reason for such termination. 

(y) “Stock” means the common stock of the Company, as adjusted from time to time in accordance
with Section 4.2. 
 (z) “Stock Purchase Agreement” means a written agreement
between the Company and a Participant setting forth the terms, conditions and restrictions of the Stock Purchase Right granted to the Participant and any shares acquired upon the exercise thereof. A Stock Purchase Agreement may consist of a form of
“Notice of Grant of Stock Purchase Right” and a form of “Stock Purchase Agreement” incorporated therein by reference, or such other form or forms as the Board may approve from time to time. 

(aa) “Stock Purchase Right” means a right granted under Section 7 to purchase Stock pursuant
to the terms and conditions of the Plan. 
 (bb) “Subsidiary Corporation” means any
present or future “subsidiary corporation” of the Company, as defined in Section 424(f) of the Code. 
 (cc)
“Ten Percent Shareholder” means a person who, at the time an Award is granted to such person, owns stock possessing more than ten percent (10%) of the total combined voting power (as defined in
Section 194.5 of the California Corporations Code) of all classes of stock of a Participating Company within the meaning of Section 422(b)(6) of the Code. 
 2.2 Construction. Captions and titles contained herein are for convenience only and shall not affect the meaning or interpretation of any provision of the Plan. Except when otherwise indicated by
the context, the singular shall include the plural and the plural shall include the singular. Use of the term “or” is not intended to be exclusive, unless the context clearly requires otherwise. 

  
 4 

 3. ADMINISTRATION. 

3.1 Administration by the Board. The Plan shall be administered by the Board. All questions of interpretation of the Plan or of any
Award shall be determined by the Board, and such determinations shall be final and binding upon all persons having an interest in the Plan or such Award. 
 3.2 Authority of Officers. Any Officer shall have the authority to act on behalf of the Company with respect to any matter, right, obligation, determination or election which is the responsibility
of or which is allocated to the Company herein, provided the Officer has apparent authority with respect to such matter, right, obligation, determination or election. 
 3.3 Powers of the Board. In addition to any other powers set forth in the Plan and subject to the provisions of the Plan, the Board shall have the full and final power and authority,
in its discretion: 
 (a) to determine the persons to whom, and the time or times at which, Awards shall be granted and the
number of shares of Stock to be subject to each Award; 
 (b) to designate Options as Incentive Stock Options or Nonstatutory
Stock Options; 
 (c) to determine the Fair Market Value of shares of Stock or other property; 

(d) to determine the terms, conditions and restrictions applicable to each Award (which need not be identical) and any shares acquired
upon the exercise thereof, including, without limitation, (i) the exercise price of the Award, (ii) the method of payment for shares purchased upon the exercise of the Award, (iii) the method for satisfaction of any tax withholding
obligation arising in connection with the Award or such shares, including by the withholding or delivery of shares of stock, (iv) the timing, terms and conditions of the exercisability of the Award or the vesting of any shares acquired upon the
exercise thereof, (v) the time of the expiration of the Award, (vi) the effect of the Participant’s termination of Service on any of the foregoing, and (vii) all other terms, conditions and restrictions applicable to the Award or
such shares not inconsistent with the terms of the Plan; 
 (e) to approve one or more forms of Option Agreement and Stock
Purchase Agreement; 
 (f) to amend, modify, extend, cancel or renew any Award or to waive any restrictions or conditions
applicable to any Award or any shares acquired upon the exercise thereof; 

  
 5 

 (g) to accelerate, continue, extend or defer the exercisability of any Award or the
vesting of any shares acquired upon the exercise thereof, including with respect to the period following a Participant’s termination of Service; 
 (h) to prescribe, amend or rescind rules, guidelines and policies relating to the Plan, or to adopt supplements to, or alternative versions of, the Plan, including, without limitation, as the Board deems
necessary or desirable to comply with the laws of, or to accommodate the tax policy or custom of, foreign jurisdictions whose citizens may be granted Awards; and 
 (i) to correct any defect, supply any omission or reconcile any inconsistency in the Plan or any Option Agreement or Stock Purchase Agreement and to make all other determinations and take such other
actions with respect to the Plan or any Award as the Board may deem advisable to the extent not inconsistent with the provisions of the Plan or applicable law. 
 3.4 Administration with Respect to Insiders. With respect to participation by Insiders in the Plan, at any time that any class of equity security of the Company is registered pursuant to
Section 12 of the Exchange Act, the Plan shall be administered in compliance with the requirements, if any, of Rule 16b-3. 
 3.5 Indemnification. In addition to such other rights of indemnification as they may have as members of the Board or officers or employees of the Participating Company Group, members of the Board
and any officers or employees of the Participating Company Group to whom authority to act for the Board or the Company is delegated shall be indemnified by the Company against all reasonable expenses, including attorneys’ fees, actually and
necessarily incurred in connection with the defense of any action, suit or proceeding, or in connection with any appeal therein, to which they or any of them may be a party by reason of any action taken or failure to act under or in connection with
the Plan, or any right granted hereunder, and against all amounts paid by them in settlement thereof (provided such settlement is approved by independent legal counsel selected by the Company) or paid by them in satisfaction of a judgment in any
such action, suit or proceeding, except in relation to matters as to which it shall be adjudged in such action, suit or proceeding that such person is liable for gross negligence, bad faith or intentional misconduct in duties; provided, however,
that within sixty (60) days after the institution of such action, suit or proceeding, such person shall offer to the Company, in writing, the opportunity at its own expense to handle and defend the same. 

4. SHARES SUBJECT TO PLAN. 

4.1 Maximum Number of Shares Issuable. Subject to adjustment as provided in Section 4.2, the maximum aggregate number of
shares of Stock that may be issued under the Plan shall be seven million five hundred seventy-five thousand (7,575,000) shall consist of authorized but unissued or reacquired shares of Stock or any combination thereof. If an outstanding Award
for any reason expires or is terminated or canceled or if shares of Stock are acquired upon the exercise of an Award subject to a Company repurchase option and are repurchased by the Company at the Participant’s exercise or purchase price, the
shares of Stock allocable to the unexercised portion of such Award or such repurchased shares of Stock shall 

  
 6 

 
again be available for issuance under the Plan. However, except as adjusted pursuant to Section 4.2, in no event shall more than seven million five hundred seventy-five thousand
(7,575,000) shares of Stock be available for issuance pursuant to the exercise of Incentive Stock Options (the “ISO Share Limit”). Notwithstanding the foregoing, at any such time as the offer and sale of
securities pursuant to the Plan is subject to compliance with Section 260.140.45 of Title 10 of the California Code of Regulations (“Section 260.140.45”), the total number of shares of Stock issuable upon
the exercise of all outstanding Awards (together with options outstanding under any other stock plan of the Company) and the total number of shares provided for under any stock bonus or similar plan of the Company shall not exceed thirty percent
(30%) (or such other higher percentage limitation as may be approved by the shareholders of the Company pursuant to Section 260.140.45) of the then outstanding shares of the Company as calculated in accordance with the conditions and
exclusions of Section 260.140.45. 
 4.2 Adjustments for Changes in Capital Structure. Subject to any
required action by the shareholders of the Company, in the event of any change in the Stock effected without receipt of consideration by the Company, whether through merger, consolidation, reorganization, reincorporation, recapitalization,
reclassification, stock dividend, stock split, reverse stock split, split-up, split-off, spin-off, combination of shares, exchange of shares, or similar change in the capital structure of the Company, or in the event of payment of a dividend or
distribution to the shareholders of the Company in a form other than Stock (excepting normal cash dividends) that has a material effect on the Fair Market Value of shares of Stock, appropriate and proportionate adjustments shall be made in the
number and class of shares subject to the Plan and to any outstanding Options, in the ISO Share Limit set forth in Section 4.1, and in the exercise price per share of any outstanding Options in order to prevent dilution or enlargement of
Optionees’ rights under the Plan. For purposes of the foregoing, conversion of any convertible securities of the Company shall not be treated as “effected without receipt of consideration by the Company.” Any fractional share
resulting from an adjustment pursuant to this Section 4.2 shall be rounded down to the nearest whole number, and in no event may the exercise price of any Option be decreased to an amount less than the par value, if any, of the stock subject to
the Option. Such adjustments shall be determined by the Board, and its determination shall be final, binding and conclusive. 

5. ELIGIBILITY AND OPTION LIMITATIONS.

 5.1 Persons Eligible for Awards. Awards may be granted only to Employees, Consultants, and Directors.
Eligible persons may be granted more than one (1) Award. However, eligibility in accordance with this Section shall not entitle any person to be granted an Award, or, having been granted an Award, to be granted an additional Award. 

5.2 Option Grant Restrictions. An Incentive Stock Option may be granted only to a person who is an Employee on the
effective date of grant of the Option to such person. Any person who is not an Employee on the effective date of the grant of an Option to such person may be granted only a Nonstatutory Stock Option. 

5.3 Fair Market Value Limitation. To the extent that options designated as Incentive Stock Options (granted under
all stock plans of the Participating Company Group, including the Plan) become exercisable by a Participant for the first time during any calendar 

  
 7 

 
year for stock having a Fair Market Value greater than One Hundred Thousand Dollars ($100,000), the portions of such options which exceed such amount shall be treated as Nonstatutory Stock
Options. For purposes of this Section 5.3, options designated as Incentive Stock Options shall be taken into account in the order in which they were granted, and the Fair Market Value of stock shall be determined as of the time the option with
respect to such stock is granted. If the Code is amended to provide for a different limitation from that set forth in this Section 5.3, such different limitation shall be deemed incorporated herein effective as of the date and with respect to
such Options as required or permitted by such amendment to the Code. If an Option is treated as an Incentive Stock Option in part and as a Nonstatutory Stock Option in part by reason of the limitation set forth in this Section 5.3, the
Participant may designate which portion of such Option the Participant is exercising. In the absence of such designation, the Participant shall be deemed to have exercised the Incentive Stock Option portion of the Option first. Separate certificates
representing each such portion shall be issued upon the exercise of the Option. 
 6. TERMS
AND CONDITIONS OF OPTIONS. 
 Options shall be
evidenced by Option Agreements specifying the number of shares of Stock covered thereby, in such form as the Board shall from time to time establish. No Option or purported Option shall be a valid and binding obligation of the Company unless
evidenced by a fully executed Option Agreement. Option Agreements may incorporate all or any of the terms of the Plan by reference and shall comply with and be subject to the following terms and conditions: 

6.1 Exercise Price. The exercise price for each Option shall be established in the discretion of the Board;
provided, however, that (a) the exercise price per share for an Option (whether an Incentive Stock Option or a Nonstatutory Stock Option) shall be not less than the Fair Market Value of a share of Stock on the effective date of grant of the
Option, and (b) no Option granted to a Ten Percent Shareholder shall have an exercise price per share less than one hundred ten percent (110%) of the Fair Market Value of a share of Stock on the effective date of grant of the Option.
Notwithstanding the foregoing, an Option (whether an Incentive Stock Option or a Nonstatutory Stock Option) may be granted with an exercise price lower than the minimum exercise price set forth above if such Option is granted pursuant to an
assumption or substitution for another option in a manner qualifying under the provisions of Section 409A and 424(a) of the Code. 
 6.2 Exercisability and Term of Options. Options shall be exercisable at such time or times, or upon such event or events, and subject to such terms, conditions, performance criteria
and restrictions as shall be determined by the Board and set forth in the Option Agreement evidencing such Option; provided, however, that (a) no Option shall be exercisable after the expiration of ten (10) years after the effective date
of grant of such Option, (b) no Incentive Stock Option granted to a Ten Percent Shareholder shall be exercisable after the expiration of five (5) years after the effective date of grant of such Option, and (c) with the exception of an
Option granted to an Officer, a Director or a Consultant, no Option shall become exercisable at a rate less than twenty percent (20%) per year over a period of five (5) years from the effective date of grant of such Option, subject to the
Participant’s continued Service. Subject to the foregoing, unless otherwise specified by the Board in the grant of an Option, any Option granted hereunder shall terminate ten (10) years after the effective date of grant of the Option,
unless earlier terminated in accordance with its provisions. 

  
 8 

 6.3 Payment of Exercise Price. 

(a) Forms of Consideration Authorized. Except as otherwise provided below, payment of the exercise price for the number of
shares of Stock being purchased pursuant to any Option shall be made (i) in cash, by check or cash equivalent, (ii) by tender to the Company, or attestation to the ownership, of shares of Stock owned by the Participant having a Fair Market
Value not less than the exercise price, (iii) by delivery of a properly executed notice together with irrevocable instructions to a broker providing for the assignment to the Company of the proceeds of a sale or loan with respect to some or all
of the shares being acquired upon the exercise of the Option (including, without limitation, through an exercise complying with the provisions of Regulation T as promulgated from time to time by the Board of Governors of the Federal Reserve
System) (a “Cashless Exercise”), (iv) by such other consideration as may be approved by the Board from time to time to the extent permitted by applicable law, or (v) by any combination thereof. The
Board may at any time or from time to time, by approval of or by amendment to the standard forms of Option Agreement described in Section 8, or by other means, grant Options which do not permit all of the foregoing forms of consideration to be
used in payment of the exercise price or which otherwise restrict one or more forms of consideration. 
 (b) Limitations
on Forms of Consideration. 
 (i) Tender of Stock. Notwithstanding the foregoing, an Option may not be exercised
by tender to the Company, or attestation to the ownership, of shares of Stock to the extent such tender or attestation would constitute a violation of the provisions of any law, regulation or agreement restricting the redemption of the
Company’s stock. Unless otherwise provided by the Board, an Option may not be exercised by tender to the Company, or attestation to the ownership, of shares of Stock unless such shares either have been owned by the Participant for more than six
(6) months (and were not used for another Option exercise by attestation during such period) or were not acquired, directly or indirectly, from the Company. 
 (ii) Cashless Exercise. The Company reserves, at any and all times, the right, in the Company’s sole and absolute discretion, to establish, decline to approve or terminate any program or
procedures for the exercise of Options by means of a Cashless Exercise. 
 6.4 Effect of Termination of Service.

 (a) Option Exercisability. Subject to earlier termination of the Option as otherwise provided herein
and unless otherwise provided by the Board in the grant of an Option and set forth in the Option Agreement, an Option shall be exercisable after a Participant’s termination of Service only during the applicable time period determined in
accordance with this Section 6.4 and thereafter shall terminate: 
 (i) Disability. If the Participant’s
Service terminates because of the Disability of the Participant, the Option, to the extent unexercised and exercisable on the 

  
 9 

 
date on which the Participant’s Service terminated, may be exercised by the Participant (or the Participant’s guardian or legal representative) at any time prior to the expiration of
twelve (12) months (or such longer period of time as determined by the Board, in its discretion) after the date on which the Participant’s Service terminated, but in any event no later than the date of expiration of the Option’s term
as set forth in the Option Agreement evidencing such Option (the “Option Expiration Date”). 
 (ii) Death. If the Participant’s Service terminates because of the death of the Participant, the Option, to the extent unexercised and exercisable on the date on which the Participant’s
Service terminated, may be exercised by the Participant’s legal representative or other person who acquired the right to exercise the Option by reason of the Participant’s death at any time prior to the expiration of twelve
(12) months (or such longer period of time as determined by the Board, in its discretion) after the date on which the Participant’s Service terminated, but in any event no later than the Option Expiration Date. The Participant’s
Service shall be deemed to have terminated on account of death if the Participant dies within three (3) months (or such longer period of time as determined by the Board, in its discretion) after the Participant’s termination of Service.

 (iii) Termination for Cause. Notwithstanding any other provision of the Plan to the contrary, if the
Participant’s Service with the Participating Company Group is terminated for Cause, as defined by the Participant’s Option Agreement or contract of employment or service (or, if not defined in any of the foregoing, as defined below), the
Option shall terminate and cease to be exercisable immediately upon such termination of Service. Unless otherwise defined by the Participant’s Option Agreement or contract of employment or service, for purposes of this Section 6.4(a)(iii)
“Cause” shall mean any of the following: (1) the Participant’s theft, dishonesty, or falsification of any Participating Company documents or records; (2) the Participant’s improper use or
disclosure of a Participating Company’s confidential or proprietary information; (3) any action by the Participant which has a material detrimental effect on a Participating Company’s reputation or business; (4) the
Participant’s failure or inability to perform any reasonable assigned duties after written notice from a Participating Company of, and a reasonable opportunity to cure, such failure or inability; (5) any material breach by the Participant
of any employment or service agreement between the Participant and a Participating Company, which breach is not cured pursuant to the terms of such agreement; or (6) the Participant’s conviction (including any plea of guilty or nolo
contendere) of any criminal act which impairs the Participant’s ability to perform his or her duties with a Participating Company. 
 (iv) Other Termination of Service. If the Participant’s Service terminates for any reason, except Disability, death or Cause, the Option, to the extent unexercised and exercisable by the
Participant on the date on which the Participant’s Service terminated, may be exercised by the Participant at any time prior to the expiration of three (3) months (or such longer period of time as determined by the Board, in its
discretion) after the date on which the Participant’s Service terminated, but in any event no later than the Option Expiration Date. 
 (b) Extension if Exercise Prevented by Law. Notwithstanding the foregoing other than termination for Cause, if the exercise of an Option within the applicable

  
 10 

 
time periods set forth in Section 6.4(a) is prevented by the provisions of Section 11 below, the Option shall remain exercisable until three (3) months (or such longer period of
time as determined by the Board, in its discretion) after the date the Participant is notified by the Company that the Option is exercisable, but in any event no later than the Option Expiration Date. 

(c) Extension if Participant Subject to Section 16(b). Notwithstanding the foregoing other than termination
for Cause, if a sale within the applicable time periods set forth in Section 6.4(a) of shares acquired upon the exercise of the Option would subject the Participant to suit under Section 16(b) of the Exchange Act, the Option shall remain
exercisable until the earliest to occur of (i) the tenth (10th) day following the date on which a sale of such shares by the Participant would no longer be subject to such suit, (ii) the one hundred and ninetieth (190th) day
after the Participant’s termination of Service, or (iii) the Option Expiration Date. 
 6.5 Transferability of
Options. During the lifetime of the Participant, an Option shall be exercisable only by the Participant or the Participant’s guardian or legal representative. No Option shall be assignable or transferable by the Participant, except by will
or by the laws of descent and distribution. Notwithstanding the foregoing, to the extent permitted by the Board, in its discretion, and set forth in the Option Agreement evidencing such Option, a Nonstatutory Stock Option shall be assignable or
transferable subject to the applicable limitations, if any, described in Section 260.140.41 of Title 10 of the California Code of Regulations, Rule 701 under the Securities Act, and the General Instructions to Form S-8 Registration Statement
under the Securities Act. 
 7. TERMS AND CONDITIONS OF
STOCK PURCHASE RIGHTS. 
 Stock Purchase Rights shall be
evidenced by Stock Purchase Agreements, specifying the number of shares of Stock covered thereby, in such form as the Board shall from time to time establish. No Stock Purchase Right or purported Stock Purchase Right shall be a valid and binding
obligation of the Company unless evidenced by a fully executed Stock Purchase Agreement. Stock Purchase Agreements may incorporate all or any of the terms of the Plan by reference and shall comply with and be subject to the following terms and
conditions: 
 7.1 Purchase Price. The purchase price under each Stock Purchase Right shall be established
by the Board; provided, however, that (a) the purchase price per share shall be at least eighty-five percent (85%) of the Fair Market Value of a share of Stock either on the effective date of grant of the Stock Purchase Right or on the
date on which the purchase is consummated and (b) the purchase price per share under a Stock Purchase Right granted to a Ten Percent Shareholder shall be at least one hundred percent (100%) of the Fair Market Value of a share of Stock
either on the effective date of grant of the Stock Purchase Right or on the date on which the purchase is consummated. 
 7.2
Purchase Period. A Stock Purchase Right shall be exercisable within a period established by the Board, which shall in no event exceed thirty (30) days from the effective date of the grant of the Stock Purchase Right.

  
 11 

 7.3 Payment of Purchase Price. Except as otherwise provided below, payment of the
purchase price for the number of shares of Stock being purchased pursuant to any Stock Purchase Right shall be made (a) in cash, by check, or cash equivalent, (b) in the form of the Participant’s past service rendered to a
Participating Company or for its benefit having a value not less than the aggregate purchase price of the shares being acquired, (c) by such other consideration as may be approved by the Board from time to time to the extent permitted by
applicable law, or (d) by any combination thereof. The Board may at any time or from time to time, by adoption of or by amendment to the standard form of Stock Purchase Agreement described in Section 8, or by other means, grant Stock
Purchase Rights which do not permit all of the foregoing forms of consideration to be used in payment of the purchase price or which otherwise restrict one or more forms of consideration. 

7.4 Vesting and Restrictions on Transfer. Shares issued pursuant to any Stock Purchase Right may or may not be made subject to
vesting conditioned upon the satisfaction of such Service requirements, conditions, restrictions or performance criteria (the “Vesting Conditions”) as shall be established by the Board and set forth in the Stock
Purchase Agreement evidencing such Award. During any period (the “Restriction Period”) in which shares acquired pursuant to a Stock Purchase Right remain subject to Vesting Conditions, such shares may not be
sold, exchanged, transferred, pledged, assigned or otherwise disposed of other than pursuant to an Ownership Change Event, as defined in Section 9.1, or as provided in Section 7.5. Upon request by the Company, each Participant shall
execute any agreement evidencing such transfer restrictions prior to the receipt of shares of Stock hereunder and shall promptly present to the Company any and all certificates representing shares of Stock acquired hereunder for the placement on
such certificates of appropriate legends evidencing any such transfer restrictions. 
 7.5 Effect of Termination of
Service. Unless otherwise provided by the Board in the grant of a Stock Purchase Right and set forth in the Stock Purchase Agreement, if a Participant’s Service terminates for any reason, whether voluntary or involuntary (including the
Participant’s death or disability), then the Company shall have the option to repurchase for the purchase price paid by the Participant any shares acquired by the Participant pursuant to a Stock Purchase Right which remain subject to Vesting
Conditions as of the date of the Participant’s termination of Service; provided, however, that with the exception of shares acquired pursuant to a Stock Purchase Right by an Officer, a Director or a Consultant, the Company’s repurchase
option must lapse at the rate of at least twenty percent (20%) of the shares per year over the period of five (5) years from the effective date of grant of the Stock Purchase Right (without regard to the date on which the Stock Purchase
Right was exercised) and the repurchase option must be exercised, if at all, for cash or cancellation of purchase money indebtedness for the shares within ninety (90) days following the Participant’s termination of Service. The Company
shall have the right to assign at any time any repurchase right it may have, whether or not such right is then exercisable, to one or more persons as may be selected by the Company. 

7.6 Nontransferability of Stock Purchase Rights. Rights to acquire shares of Stock pursuant to a Stock Purchase Right may
not be assigned or transferred in any manner except by will or the laws of descent and distribution, and, during the lifetime of the Participant, shall be exercisable only by the Participant. 

  
 12 

 8. STANDARD FORMS OF
AGREEMENTS. 
 8.1 Option Agreement. Unless otherwise provided by the Board at the
time the Option is granted, an Option shall comply with and be subject to the terms and conditions set forth in the form of Option Agreement approved by the Board concurrently with its adoption of the Plan and as amended from time to time.

 8.2 Stock Purchase Agreement. Unless otherwise provided by the Board at the time the Stock Purchase Right is granted,
a Stock Purchase Right shall be subject to the terms and conditions set forth in the form of Stock Purchase Agreement approved by the Board concurrently with its adoption of the Plan and as amended from time to time. 

8.3 Authority to Vary Terms. The Board shall have the authority from time to time to vary the terms of any standard form of
agreement described in this Section 8 either in connection with the grant or amendment of an individual Award or in connection with the authorization of a new standard form or forms; provided, however, that the terms and conditions of any such
new, revised or amended standard form or forms of agreement are not inconsistent with the terms of the Plan or Section 409A of the Code. 
 9. CHANGE IN CONTROL. 
 9.1 Definitions. 
 (a) An “Ownership Change
Event” shall be deemed to have occurred if any of the following occurs with respect to the Company: (i) the direct or indirect sale or exchange in a single or series of related transactions by the shareholders of the Company
of more than fifty percent (50%) of the voting stock of the Company; (ii) a merger or consolidation in which the Company is a party; (iii) the sale, exchange, or transfer of all or substantially all of the assets of the Company; or
(iv) a liquidation or dissolution of the Company. 
 (b) A “Change in Control” shall
mean an Ownership Change Event or a series of related Ownership Change Events (collectively, a “Transaction”) wherein the shareholders of the Company immediately before the Transaction do not retain immediately
after the Transaction, in substantially the same proportions as their ownership of shares of the Company’s voting stock immediately before the Transaction, direct or indirect beneficial ownership of more than fifty percent (50%) of the
total combined voting power of the outstanding voting securities of the Company or, in the case of a Transaction described in Section 9.1(a)(iii), the corporation or other business entity to which the assets of the Company were transferred (the
“Transferee”), as the case may be. For purposes of the preceding sentence, indirect beneficial ownership shall include, without limitation, an interest resulting from ownership of the voting securities of one or
more corporations or other business entities which own the Company or the Transferee, as the case may be, either directly or through one or more subsidiary corporations or other business entities. The Board shall have the right to determine whether
multiple sales or exchanges of the voting securities of the Company or multiple Ownership Change Events are related, and its determination shall be final, binding and conclusive. 

  
 13 

 9.2 Effect of Change in Control on Options. 

(a) Accelerated Vesting. Notwithstanding any other provision of the Plan to the contrary, the Board, in its sole
discretion, may provide in any Award Agreement or, in the event of a Change in Control, may take such actions as it deems appropriate to provide for the acceleration of the exercisability and vesting in connection with such Change in Control of any
or all outstanding Options and shares acquired upon the exercise of such Options 
 (b) Assumption of Options. In
the event of a Change in Control, the surviving, continuing, successor, or purchasing corporation or other business entity or parent thereof, as the case may be (the “Acquiror”), may, without the consent of any
Participant, either assume the Company’s rights and obligations under outstanding Options or substitute for outstanding Options substantially equivalent options for the Acquiror’s stock. Any Options which are neither assumed by the
Acquiror in connection with the Change in Control nor exercised as of the date of the Change in Control shall terminate and cease to be outstanding effective as of the date of the Change in Control. Notwithstanding the foregoing, shares acquired
upon exercise of an Option prior to the Change in Control and any consideration received pursuant to the Change in Control with respect to such shares shall continue to be subject to all applicable provisions of the Award Agreement evidencing such
Option except as otherwise provided in such Award Agreement. Furthermore, notwithstanding the foregoing, if the corporation the stock of which is subject to the outstanding Options immediately prior to an Ownership Change Event described in
Section 9.1(a)(i) constituting a Change in Control is the surviving or continuing corporation and immediately after such Ownership Change Event less than fifty percent (50%) of the total combined voting power of its voting stock is held by
another corporation or by other corporations that are members of an affiliated group within the meaning of Section 1504(a) of the Code without regard to the provisions of Section 1504(b) of the Code, the outstanding Options shall not
terminate unless the Board otherwise provides in its discretion. 
 (c) Cash-Out of Options. The Board may, in
its sole discretion and without the consent of any Participant, determine that, upon the occurrence of a Change in Control, each or any Option outstanding immediately prior to the Change in Control shall be canceled in exchange for a payment with
respect to each vested share of Stock subject to such canceled Option in (i) cash, (ii) stock of the Company or of a corporation or other business entity a party to the Change in Control, or (iii) other property which, in any such
case, shall be in an amount having a Fair Market Value equal to the Fair Market Value of the consideration to be paid per share of Stock in the Change in Control over the exercise price per share under such Option (the
“Spread”). In the event such determination is made by the Board, the Spread (reduced by applicable withholding taxes, if any) shall be paid to Participants in respect of their canceled Options as soon as
practicable following the date of the Change in Control. 
 9.3 Effect of Change in Control on Stock Purchase Right. In
the event of a Change in Control, the Acquiror, may, without the consent of any Participant, either assume the Company’s rights and obligations under outstanding Stock Purchase Rights or substitute for outstanding Stock Purchase Rights
substantially equivalent purchase rights for the Acquiror’s stock. Any Stock Purchase Rights which are neither assumed or substituted for by the Acquiror in connection with the Change in Control nor exercised as of the date of the Change in
Control shall terminate and cease to be outstanding effective as of the date of the Change in Control. Notwithstanding the foregoing, shares acquired upon exercise of a Stock Purchase Right prior to the Change in Control and any consideration
received pursuant to the Change in Control with 

  
 14 

 
respect to such shares shall continue to be subject to all applicable provisions of the Stock Purchase Agreement evidencing such Stock Purchase Right except as otherwise provided in such Stock
Purchase Agreement. Furthermore, notwithstanding the foregoing, if the corporation the stock of which is subject to the outstanding Stock Purchase Rights immediately prior to an Ownership Change Event described in Section 9.1(a)(i) constituting
a Change in Control is the surviving or continuing corporation and immediately after such Ownership Change Event less than fifty percent (50%) of the total combined voting power of its voting stock is held by another corporation or by other
corporations that are members of an affiliated group within the meaning of Section 1504(a) of the Code without regard to the provisions of Section 1504(b) of the Code, the outstanding Stock Purchase Rights shall not terminate unless the
Board otherwise provides in its discretion. 
 9.4 Federal Excise Tax Under Section 4999 of the Code. 

(a) Excess Parachute Payment. In the event that any acceleration of vesting pursuant to an Award and any other payment or
benefit received or to be received by a Participant would subject the Participant to any excise tax pursuant to Section 4999 of the Code due to the characterization of such acceleration of vesting, payment or benefit as an “excess
parachute payment” under Section 280G of the Code, the Participant may elect, in his or her sole discretion, to reduce the amount of any acceleration of vesting called for under the Award in order to avoid such characterization.

 (b) Determination by Independent Accountants. To aid the Participant in making any election called for under
Section 9.4(a), no later than the date of the occurrence of any event that might reasonably be anticipated to result in an “excess parachute payment” to the Participant as described in Section 9.4(a), the Company shall request a
determination in writing by independent public accountants selected by the Company (the “Accountants”). As soon as practicable thereafter, the Accountants shall determine and report to the Company and the
Participant the amount of such acceleration of vesting, payments and benefits which would produce the greatest after-tax benefit to the Participant. For the purposes of such determination, the Accountants may rely on reasonable, good faith
interpretations concerning the application of Sections 280G and 4999 of the Code. The Company and the Participant shall furnish to the Accountants such information and documents as the Accountants may reasonably request in order to make their
required determination. The Company shall bear all fees and expenses the Accountants may reasonably charge in connection with their services contemplated by this Section 9.4(b). 

10. TAX WITHHOLDING. 

10.1 Tax Withholding in General. The Company shall have the right to deduct from any and all payments made under the Plan, or to
require the Participant, through payroll withholding, cash payment or otherwise, including by means of a Cashless Exercise of an Option, to make adequate provision for, the federal, state, local and foreign taxes, if any, required by law to be
withheld by the Participating Company Group with respect to an Award or the shares acquired pursuant thereto. The Company shall have no obligation to deliver shares of Stock or to release shares of Stock from an escrow established pursuant to an
Option Agreement or Stock Purchase Agreement until the Participating Company Group’s tax withholding obligations have been satisfied by the Participant. 

  
 15 

 10.2 Withholding in Shares. The Company shall have the right, but not the
obligation, to deduct from the shares of Stock issuable to a Participant upon the exercise of an Award, or to accept from the Participant the tender of, a number of whole shares of Stock having a Fair Market Value, as determined by the Company,
equal to all or any part of the tax withholding obligations of the Participating Company Group. The Fair Market Value of any shares of Stock withheld or tendered to satisfy any such tax withholding obligations shall not exceed the amount determined
by the applicable minimum statutory withholding rates. 
 11. COMPLIANCE WITH
SECURITIES LAW. 
 The grant of Awards and the issuance of shares of Stock
upon exercise of Awards shall be subject to compliance with all applicable requirements of federal, state and foreign law with respect to such securities. Awards may not be exercised if the issuance of shares of Stock upon exercise would constitute
a violation of any applicable federal, state or foreign securities laws or other law or regulations or the requirements of any stock exchange or market system upon which the Stock may then be listed. In addition, no Award may be exercised unless
(a) a registration statement under the Securities Act shall at the time of exercise of the Award be in effect with respect to the shares issuable upon exercise of the Award or (b) in the opinion of legal counsel to the Company, the shares
issuable upon exercise of the Award may be issued in accordance with the terms of an applicable exemption from the registration requirements of the Securities Act. The inability of the Company to obtain from any regulatory body having jurisdiction
the authority, if any, deemed by the Company’s legal counsel to be necessary to the lawful issuance and sale of any shares hereunder shall relieve the Company of any liability in respect of the failure to issue or sell such shares as to which
such requisite authority shall not have been obtained. As a condition to the exercise of any Award, the Company may require the Participant to satisfy any qualifications that may be necessary or appropriate, to evidence compliance with any
applicable law or regulation and to make any representation or warranty with respect thereto as may be requested by the Company. 
 12. TERMINATION OR AMENDMENT OF PLAN. 

The Board may terminate or amend the Plan at any time. However, subject to changes in applicable law, regulations or rules that would
permit otherwise, without the approval of the Company’s shareholders, there shall be (a) no increase in the maximum aggregate number of shares of Stock that may be issued under the Plan (except by operation of the provisions of
Section 4.2), (b) no change in the class of persons eligible to receive Incentive Stock Options, and (c) no other amendment of the Plan that would require approval of the Company’s shareholders under any applicable law,
regulation or rule. No termination or amendment of the Plan shall affect any then outstanding Award unless expressly provided by the Board. In any event, no termination or amendment of the Plan may adversely affect any then outstanding Award without
the consent of the Participant, unless such termination or amendment is required to enable an Option designated as an Incentive Stock Option to qualify as an Incentive Stock Option or is necessary to comply with any applicable law, regulation or
rule. 

  
 16 

 13. MISCELLANEOUS PROVISIONS.

 13.1 Repurchase Rights. Shares issued under the Plan may be subject to a right of first refusal, one or more repurchase
options, or other conditions and restrictions as determined by the Board in its discretion at the time the Award is granted. The Company shall have the right to assign at any time any repurchase right it may have, whether or not such right is then
exercisable, to one or more persons as may be selected by the Company. Upon request by the Company, each Participant shall execute any agreement evidencing such transfer restrictions prior to the receipt of shares of Stock hereunder and shall
promptly present to the Company any and all certificates representing shares of Stock acquired hereunder for the placement on such certificates of appropriate legends evidencing any such transfer restrictions. 

13.2 Provision of Information. At least annually, copies of the Company’s balance sheet and income statement for the just
completed fiscal year shall be made available to each Participant and purchaser of shares of Stock upon the exercise of an Award. The Company shall not be required to provide such information to key employees whose duties in connection with the
Company assure them access to equivalent information. Furthermore, the Company shall deliver to each Participant such disclosures as are required in accordance with Rule 701 under the Securities Act. 

13.3 Shareholder Approval. The Plan or any increase in the maximum aggregate number of shares of Stock issuable thereunder as
provided in Section 4.1 (the “Authorized Shares”) shall be approved by a majority of the outstanding securities of the Company entitled to vote within twelve (12) months before or after the date of
adoption thereof by the Board. Awards granted prior to security holder approval of the Plan or in excess of the Authorized Shares previously approved by the security holders shall become exercisable no earlier than the date of security holder
approval of the Plan or such increase in the Authorized Shares, as the case may be. 

  
 17 

 THE SECURITIES WHICH ARE THE SUBJECT OF THIS AGREEMENT HAVE NOT BEEN QUALIFIED WITH THE COMMISSIONER OF
CORPORATIONS OF THE STATE OF CALIFORNIA AND THE ISSUANCE OF SUCH SECURITIES OR THE PAYMENT OR RECEIPT OF ANY PART OF THE CONSIDERATION THEREFOR PRIOR TO SUCH QUALIFICATION IS UNLAWFUL, UNLESS THE SALE OF SECURITIES IS EXEMPT FROM QUALIFICATION BY
SECTION 25100, 25102, OR 25105 OF THE CALIFORNIA CORPORATIONS CODE. THE RIGHTS OF ALL PARTIES TO THIS AGREEMENT ARE EXPRESSLY CONDITIONED UPON SUCH QUALIFICATION BEING OBTAINED, UNLESS THE SALE IS SO EXEMPT. 

THE SECURITIES WHICH ARE THE SUBJECT OF THIS AGREEMENT HAVE BEEN ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR
DISTRIBUTION THEREOF. NO SUCH SALE OR DISPOSITION MAY BE EFFECTED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED UNDER THE SECURITIES ACT OF
1933. 
 TRIA BEAUTY, INC. 
 STOCK OPTION AGREEMENT 
 (US PARTICIPANT) 

Tria Beauty, Inc. has granted to the individual (the “Participant”) named in the Notice of Grant
of Stock Option (the “Notice”) to which this Stock Option Agreement (the “Option Agreement”) is attached an option (the “Option”)
to purchase certain shares of Stock upon the terms and conditions set forth in the Notice and this Option Agreement. The Option has been granted pursuant to and shall in all respects be subject to the terms and conditions of the Tria Beauty, Inc.
2004 Stock Plan (the “Plan”), as amended to the Date of Option Grant, the provisions of which are incorporated herein by reference. By signing the Notice, the Participant: (a) represents that the
Participant has received copies of, and has read and is familiar with the terms and conditions of, the Notice, the Plan and this Option Agreement, (b) accepts the Option subject to all of the terms and conditions of the Notice, the Plan and
this Option Agreement, and (c) agrees to accept as binding, conclusive and final all decisions or interpretations of the Board upon any questions arising under the Notice, the Plan or this Option Agreement. 

1. DEFINITIONS AND CONSTRUCTION. 

1.1 Definitions. Unless otherwise defined herein, capitalized terms shall have the meanings assigned to such terms in the Notice or
the Plan. 
 1.2 Construction. Captions and titles contained herein are for convenience only and shall not affect the
meaning or interpretation of any provision of this Option Agreement. Except when otherwise indicated by the context, the singular shall include the plural and the plural shall include the singular. Use of the term “or” is not intended to
be exclusive, unless the context clearly requires otherwise. 

  
 1 

 2. TAX CONSEQUENCES. 

2.1 Tax Status of Option. This Option is intended to have the tax status designated in the Notice. 

(a) Incentive Stock Option. If the Notice so designates, this Option is intended to be an Incentive Stock Option within
the meaning of Section 422(b) of the Code, but the Company does not represent or warrant that this Option qualifies as such. The Participant should consult with the Participant’s own tax advisor regarding the tax effects of this Option and
the requirements necessary to obtain favorable income tax treatment under Section 422 of the Code, including, but not limited to, holding period requirements. (NOTE TO PARTICIPANT: If the Option is exercised more than three (3) months
after the date on which you cease to be an Employee (other than by reason of your death or permanent and total disability as defined in Section 22(e)(3) of the Code), the Option will be treated as a Nonstatutory Stock Option and not as an
Incentive Stock Option to the extent required by Section 422 of the Code.) 
 (b) Nonstatutory Stock Option.
If the Notice so designates, this Option is intended to be a Nonstatutory Stock Option and shall not be treated as an Incentive Stock Option within the meaning of Section 422(b) of the Code. 

2.2 ISO Fair Market Value Limitation. If the Notice designates this Option as an Incentive Stock Option, then to the extent
that the Option (together with all Incentive Stock Options granted to the Participant under all stock option plans of the Participating Company Group, including the Plan) becomes exercisable for the first time during any calendar year for shares
having a Fair Market Value greater than One Hundred Thousand Dollars ($100,000), the portion of such options which exceeds such amount will be treated as Nonstatutory Stock Options. For purposes of this Section 2.2, options designated as
Incentive Stock Options are taken into account in the order in which they were granted, and the Fair Market Value of stock is determined as of the time the option with respect to such stock is granted. If the Code is amended to provide for a
different limitation from that set forth in this Section 2.2, such different limitation shall be deemed incorporated herein effective as of the date required or permitted by such amendment to the Code. If the Option is treated as an Incentive
Stock Option in part and as a Nonstatutory Stock Option in part by reason of the limitation set forth in this Section 2.2, the Participant may designate which portion of such Option the Participant is exercising. In the absence of such
designation, the Participant shall be deemed to have exercised the Incentive Stock Option portion of the Option first. Separate certificates representing each such portion shall be issued upon the exercise of the Option. (NOTE TO PARTICIPANT: If the
aggregate Exercise Price of the Option (that is, the Exercise Price multiplied by the Number of Option Shares) plus the aggregate exercise price of any other Incentive Stock Options you hold (whether granted pursuant to the Plan or any other stock
option plan of the Participating Company Group) is greater than $100,000, you should contact the Chief Financial Officer of the Company to ascertain whether the entire Option qualifies as an Incentive Stock Option.) 

  
 2 

 2.3 Section 409A of the Code. Unless otherwise expressly noted in the Notice,
the Exercise Price represents an amount the Company believes to be no less than the Fair Market Value of a share of Stock as of the Date of Option Grant (as defined in the Notice), determined in good faith in compliance with the requirements of
Section 409A of the Code. However, there is no guarantee that the Internal Revenue Service (the “IRS”) will agree with the Company’s determination. A subsequent IRS determination that the Exercise
Price is less than such Fair Market Value could result in adverse tax consequences to the Participant. By signing the Notice, the Participant agrees that the Company, its directors, officers and shareholders shall not be held liable for any tax,
penalty, interest or cost incurred by the Participant as a result of such determination by the IRS. The Participant is urged to consult with his or her own tax advisor regarding the tax consequences of the Option, including the application of
Section 409A. 
 3. ADMINISTRATION. 

All questions of interpretation concerning this Option Agreement shall be determined by the Board. All determinations by the Board shall
be final and binding upon all persons having an interest in the Option. Any Officer shall have the authority to act on behalf of the Company with respect to any matter, right, obligation, or election which is the responsibility of or which is
allocated to the Company herein, provided the Officer has apparent authority with respect to such matter, right, obligation, or election. 
 4. EXERCISE OF THE OPTION. 
 4.1 Right to Exercise. Except as otherwise provided herein, the Option shall be exercisable on and after the Initial Vesting Date and prior to the termination of the Option (as provided in
Section 6) in an amount not to exceed the number of Vested Shares less the number of shares previously acquired upon exercise of the Option, subject to the Company’s repurchase rights set forth in Section 11. In no event shall the
Option be exercisable for more shares than the Number of Option Shares, as adjusted pursuant to Section 9. 
 4.2 Method
of Exercise. Exercise of the Option shall be by written notice to the Company which must state the election to exercise the Option, the number of whole shares of Stock for which the Option is being exercised and such other representations and
agreements as to the Participant’s investment intent with respect to such shares as may be required pursuant to the provisions of this Option Agreement. The written notice must be signed by the Participant and must be delivered in person, by
certified or registered mail, return receipt requested, by confirmed facsimile transmission, or by such other means as the Company may permit, to the Chief Financial Officer of the Company, or other authorized representative of the Participating
Company Group, prior to the termination of the Option as set forth in Section 6, accompanied by full payment of the aggregate Exercise Price for the number of shares of Stock being purchased. The Option shall be deemed to be exercised upon
receipt by the Company of such written notice and the aggregate Exercise Price. 

  
 3 

 4.3 Payment of Exercise Price. 

(a) Forms of Consideration Authorized. Except as otherwise provided below, payment of the aggregate Exercise Price for the
number of shares of Stock for which the Option is being exercised shall be made (i) in cash, by check, or cash equivalent, (ii) by tender to the Company, or attestation to the ownership, of whole shares of Stock owned by the Participant
having a Fair Market Value not less than the aggregate Exercise Price, (iii) by means of a Cashless Exercise, as defined in Section 4.3(b), or (iv) by any combination of the foregoing. 

(b) Limitations on Forms of Consideration. 
 (i) Tender of Stock. Notwithstanding the foregoing, the Option may not be exercised by tender to the Company, or attestation to the ownership, of shares of Stock to the extent such tender or
attestation would constitute a violation of the provisions of any law, regulation or agreement restricting the redemption of the Company’s stock. The Option may not be exercised by tender to the Company, or attestation to the ownership, of
shares of Stock unless such shares either have been owned by the Participant for more than six (6) months (and not used for another option exercise by attestation during such period) or were not acquired, directly or indirectly, from the
Company. 
 (ii) Cashless Exercise. A “Cashless Exercise” means the delivery of a
properly executed notice together with irrevocable instructions to a broker in a form acceptable to the Company providing for the assignment to the Company of the proceeds of a sale or loan with respect to some or all of the shares of Stock acquired
upon the exercise of the Option pursuant to a program or procedure approved by the Company (including, without limitation, through an exercise complying with the provisions of Regulation T as promulgated from time to time by the Board of
Governors of the Federal Reserve System). The Company reserves, at any and all times, the right, in the Company’s sole and absolute discretion, to decline to approve or terminate any such program or procedure. 

4.4 Tax Withholding. At the time the Option is exercised, in whole or in part, or at any time thereafter as requested by the
Company, the Participant hereby authorizes withholding from payroll and any other amounts payable to the Participant, and otherwise agrees to make adequate provision for (including by means of a Cashless Exercise to the extent permitted by the
Company), any sums required to satisfy the federal, state, local and foreign tax withholding obligations of the Participating Company Group, if any, which arise in connection with the Option, including, without limitation, obligations arising upon
(i) the exercise, in whole or in part, of the Option or (ii) the transfer, in whole or in part, of any shares acquired upon exercise of the Option. The Option is not exercisable unless the tax withholding obligations of the Participating
Company Group are satisfied. Accordingly, the Company shall have no obligation to deliver shares of Stock until the tax withholding obligations of the Participating Company Group have been satisfied by the Participant. 

4.5 Certificate Registration. Except in the event the Exercise Price is paid by means of a Cashless Exercise, the certificate for
the shares as to which the Option is exercised shall be registered in the name of the Participant, or, if applicable, in the names of the heirs of the Participant. 

  
 4 

 4.6 Restrictions on Grant of the Option and Issuance of Shares. The grant of the
Option and the issuance of shares of Stock upon exercise of the Option shall be subject to compliance with all applicable requirements of federal, state or foreign law with respect to such securities. The Option may not be exercised if the issuance
of shares of Stock upon exercise would constitute a violation of any applicable federal, state or foreign securities laws or other law or regulations or the requirements of any stock exchange or market system upon which the Stock may then be listed.
In addition, the Option may not be exercised unless (i) a registration statement under the Securities Act shall at the time of exercise of the Option be in effect with respect to the shares issuable upon exercise of the Option or (ii) in
the opinion of legal counsel to the Company, the shares issuable upon exercise of the Option may be issued in accordance with the terms of an applicable exemption from the registration requirements of the Securities Act. THE PARTICIPANT IS CAUTIONED
THAT THE OPTION MAY NOT BE EXERCISED UNLESS THE FOREGOING CONDITIONS ARE SATISFIED. ACCORDINGLY, THE PARTICIPANT MAY NOT BE ABLE TO EXERCISE THE OPTION WHEN DESIRED EVEN THOUGH THE OPTION IS VESTED. The inability of the Company to obtain from any
regulatory body having jurisdiction the authority, if any, deemed by the Company’s legal counsel to be necessary to the lawful issuance and sale of any shares subject to the Option shall relieve the Company of any liability in respect of the
failure to issue or sell such shares as to which such requisite authority shall not have been obtained. As a condition to the exercise of the Option, the Company may require the Participant to satisfy any qualifications that may be necessary or
appropriate, to evidence compliance with any applicable law or regulation and to make any representation or warranty with respect thereto as may be requested by the Company. 
 4.7 Fractional Shares. The Company shall not be required to issue fractional shares upon the exercise of the Option. 
 5. NONTRANSFERABILITY OF THE OPTION. 
 The Option may be exercised during the lifetime of the Participant only by the Participant or the Participant’s guardian or legal representative and may not be assigned or transferred in any manner
except by will or by the laws of descent and distribution. Following the death of the Participant, the Option, to the extent provided in Section 7, may be exercised by the Participant’s legal representative or by any person empowered to do
so under the deceased Participant’s will or under the then applicable laws of descent and distribution. 
 6.
TERMINATION OF THE OPTION. 
 The Option
shall terminate and may no longer be exercised after the first to occur of (a) the close of business on the Option Expiration Date, (b) the close of business on the last date for exercising the Option following termination of the
Participant’s Service as described in Section 7, or (c) a Change in Control to the extent provided in Section 8. 

  
 5 

 7. EFFECT OF TERMINATION
OF SERVICE. 
 7.1 Option Exercisability. 

(a) Disability. If the Participant’s Service terminates because of the Disability of the Participant, the
Option, to the extent unexercised and exercisable on the date on which the Participant’s Service terminated, may be exercised by the Participant (or the Participant’s guardian or legal representative) at any time prior to the expiration of
twelve (12) months after the date on which the Participant’s Service terminated, but in any event no later than the Option Expiration Date. 
 (b) Death. If the Participant’s Service terminates because of the death of the Participant, the Option, to the extent unexercised and exercisable on the date on which the
Participant’s Service terminated, may be exercised by the Participant’s legal representative or other person who acquired the right to exercise the Option by reason of the Participant’s death at any time prior to the expiration of
twelve (12) months after the date on which the Participant’s Service terminated, but in any event no later than the Option Expiration Date. The Participant’s Service shall be deemed to have terminated on account of death if the
Participant dies within three (3) months after the Participant’s termination of Service. 
 (c) Termination for
Cause. Notwithstanding any other provision of this Option Agreement, if the Participant’s Service is terminated for Cause (as defined below), the Option shall terminate and cease to be exercisable on the effective date of such
termination of Service. Unless otherwise defined in a contract of employment or service between the Participant and a Participating Company, for purposes of this Option Agreement “Cause” shall mean any of the
following: (i) the Participant’s theft, dishonesty, or falsification of any Participating Company documents or records; (ii) the Participant’s improper use or disclosure of a Participating Company’s confidential or
proprietary information; (iii) any action by the Participant which has a material detrimental effect on a Participating Company’s reputation or business; (iv) the Participant’s failure or inability to perform any reasonable
assigned duties after written notice from a Participating Company of, and a reasonable opportunity to cure, such failure or inability; (v) any material breach by the Participant of any employment agreement between the Participant and a
Participating Company, which breach is not cured pursuant to the terms of such agreement; or (vi) the Participant’s conviction (including any plea of guilty or nolo contendere) of any criminal act which impairs the Participant’s
ability to perform his or her duties with a Participating Company. 
 (d) Other Termination of Service. If
the Participant’s Service with the Participating Company Group terminates for any reason, except Disability, death or Cause, the Option, to the extent unexercised and exercisable by the Participant on the date on which the Participant’s
Service terminated, may be exercised by the Participant at any time prior to the expiration of three (3) months (or such other longer period of time as determined by the Board, in its discretion) after the date on which the Participant’s
Service terminated, but in any event no later than the Option Expiration Date. 
 7.2 Extension if Exercise Prevented by
Law. Notwithstanding the foregoing other than termination for Cause, if the exercise of the Option within the applicable time periods set forth in Section 7.1 is prevented by the provisions of Section 4.6, the Option
shall remain exercisable until thirty (30) days after the date the Participant is notified by the Company that the Option is exercisable, but in any event no later than the Option Expiration Date. 

  
 6 

 7.3 Extension if Participant Subject to Section 16(b). Notwithstanding the
foregoing other than termination for Cause, if a sale within the applicable time periods set forth in Section 7.1 of shares acquired upon the exercise of the Option would subject the Participant to suit under Section 16(b) of the Exchange
Act, the Option shall remain exercisable until the earliest to occur of (i) the tenth (10th) day following the date on which a sale of such shares by the Participant would no longer be subject to such suit, (ii) the one hundred and
ninetieth (190th) day after the Participant’s termination of Service, or (iii) the Option Expiration Date. 
 8.
CHANGE IN CONTROL. 
 8.1 Definitions.

 (a) An “Ownership Change Event” shall be deemed to have occurred if any of the
following occurs with respect to the Company: (i) the direct or indirect sale or exchange in a single or series of related transactions by the shareholders of the Company of more than fifty percent (50%) of the voting stock of the Company;
(ii) a merger or consolidation in which the Company is a party; (iii) the sale, exchange, or transfer of all or substantially all of the assets of the Company; or (iv) a liquidation or dissolution of the Company. 

(b) A “Change in Control” shall mean an Ownership Change Event or a series of related Ownership
Change Events (collectively, a “Transaction”) wherein the shareholders of the Company immediately before the Transaction do not retain immediately after the Transaction, in substantially the same proportions as
their ownership of shares of the Company’s voting stock immediately before the Transaction, direct or indirect beneficial ownership of more than fifty percent (50%) of the total combined voting power of the outstanding voting securities of
the Company or, in the case of a Transaction described in Section 8.1(a)(iii), the corporation or other business entity to which the assets of the Company were transferred (the “Transferee”), as the case
may be. For purposes of the preceding sentence, indirect beneficial ownership shall include, without limitation, an interest resulting from ownership of the voting securities of one or more corporations or other business entities which own the
Company or the Transferee, as the case may be, either directly or through one or more subsidiary corporations or other business entities. The Board shall have the right to determine whether multiple sales or exchanges of the voting securities of the
Company or multiple Ownership Change Events are related, and its determination shall be final, binding and conclusive. 
 8.2
Effect of Change in Control on Option. In the event of a Change in Control, the surviving, continuing, successor, or purchasing corporation or other business entity or parent thereof, as the case may be (the
“Acquiror”), may, without the consent of the Participant, either assume the Company’s rights and obligations under the Option or substitute for the Option a substantially equivalent option for the
Acquiror’s stock. The Option shall terminate and cease to be outstanding effective as of the date of the Change in Control to the extent that the Option is neither assumed by the Acquiror in connection with the Change in

  
 7 

 
Control nor exercised as of the date of the Change in Control. Notwithstanding the foregoing, shares acquired upon exercise of the Option prior to the Change in Control and any consideration
received pursuant to the Change in Control with respect to such shares shall continue to be subject to all applicable provisions of this Option Agreement except as otherwise provided herein. Furthermore, notwithstanding the foregoing, if the
corporation the stock of which is subject to the Option immediately prior to an Ownership Change Event described in Section 8.1(a)(i) constituting a Change in Control is the surviving or continuing corporation and immediately after such
Ownership Change Event less than fifty percent (50%) of the total combined voting power of its voting stock is held by another corporation or by other corporations that are members of an affiliated group within the meaning of
Section 1504(a) of the Code without regard to the provisions of Section 1504(b) of the Code, the Option shall not terminate unless the Board otherwise provides in its discretion. 

9. ADJUSTMENTS FOR CHANGES IN CAPITAL
STRUCTURE. 
 Subject to any required action by the shareholders of the Company, in the
event of any change in the Stock effected without receipt of consideration by the Company, whether through merger, consolidation, reorganization, reincorporation, recapitalization, reclassification, stock dividend, stock split, reverse stock split,
split-up, split-off, spin-off, combination of shares, exchange of shares, or similar change in the capital structure of the Company, or in the event of payment of a dividend or distribution to the shareholders of the Company in a form other than
Stock (excepting normal cash dividends) that has a material effect on the Fair Market Value of shares of Stock, appropriate and proportionate adjustments shall be made in the number, Exercise Price and class of shares subject to the Option, in order
to prevent dilution or enlargement of the Participant’s rights under the Option. For purposes of the foregoing, conversion of any convertible securities of the Company shall not be treated as “effected without receipt of consideration by
the Company.” Any fractional share resulting from an adjustment pursuant to this Section 9 shall be rounded down to the nearest whole number, and in no event may the purchase price of the Option be decreased to an amount less than the par
value, if any, of the stock subject to the Option. Such adjustments shall be determined by the Board, and its determination shall be final, binding and conclusive. 
 10. RIGHTS AS A SHAREHOLDER, DIRECTOR, EMPLOYEE OR
CONSULTANT. 
 The Participant shall have no rights as a shareholder with respect to any
shares covered by the Option until the date of the issuance of a certificate for the shares for which the Option has been exercised (as evidenced by the appropriate entry on the books of the Company or of a duly authorized transfer agent of the
Company). No adjustment shall be made for dividends, distributions or other rights for which the record date is prior to the date such certificate is issued, except as provided in Section 9. If the Participant is an Employee, the Participant
understands and acknowledges that, except as otherwise provided in a separate, written employment agreement between a Participating Company and the Participant, the Participant’s employment is “at will” and is for no specified term.
Nothing in this Option Agreement shall confer upon the Participant any right to continue in the Service of a Participating Company or interfere in any way with any right of the Participating Company Group to terminate the Participant’s Service
as a Director, an Employee or Consultant, as the case may be, at any time. 

  
 8 

 11. RIGHT OF FIRST
REFUSAL. 
 11.1 Grant of Right of First Refusal. Except as provided
in Section 11.7 below, in the event the Participant, the Participant’s legal representative, or other holder of shares acquired upon exercise of the Option proposes to sell, exchange, transfer, pledge, or otherwise dispose of any shares
acquired upon exercise of the Option (the “Transfer Shares”) to any person or entity, including, without limitation, any shareholder of a Participating Company, the Company shall have the right to repurchase the
Transfer Shares under the terms and subject to the conditions set forth in this Section 11 (the “Right of First Refusal”). 
 11.2 Notice of Proposed Transfer. Prior to any proposed transfer of the Transfer Shares, the Participant shall deliver written notice (the “Transfer
Notice”) to the Company describing fully the proposed transfer, including the number of Transfer Shares, the name and address of the proposed transferee (the “Proposed Transferee”) and, if
the transfer is voluntary, the proposed transfer price, and containing such information necessary to show the bona fide nature of the proposed transfer. In the event of a bona fide gift or involuntary transfer, the proposed transfer price shall be
deemed to be the Fair Market Value of the Transfer Shares, as determined by the Board in good faith. If the Participant proposes to transfer any Transfer Shares to more than one Proposed Transferee, the Participant shall provide a separate Transfer
Notice for the proposed transfer to each Proposed Transferee. The Transfer Notice shall be signed by both the Participant and the Proposed Transferee and must constitute a binding commitment of the Participant and the Proposed Transferee for the
transfer of the Transfer Shares to the Proposed Transferee subject only to the Right of First Refusal 
 11.3 Bona Fide
Transfer. If the Company determines that the information provided by the Participant in the Transfer Notice is insufficient to establish the bona fide nature of a proposed voluntary transfer, the Company shall give the Participant
written notice of the Participant’s failure to comply with the procedure described in this Section 11, and the Participant shall have no right to transfer the Transfer Shares without first complying with the procedure described in this
Section 11. The Participant shall not be permitted to transfer the Transfer Shares if the proposed transfer is not bona fide. 
 11.4 Exercise of Right of First Refusal. If the Company determines the proposed transfer to be bona fide, the Company shall have the right to purchase all, but not less than all, of
the Transfer Shares (except as the Company and the Participant otherwise agree) at the purchase price and on the terms set forth in the Transfer Notice by delivery to the Participant of a notice of exercise of the Right of First Refusal within
thirty (30) days after the date the Transfer Notice is delivered to the Company. The Company’s exercise or failure to exercise the Right of First Refusal with respect to any proposed transfer described in a Transfer Notice shall not affect
the Company’s right to exercise the Right of First Refusal with respect to any proposed transfer described in any other Transfer Notice, whether or not such other Transfer Notice is issued by the Participant or issued by a person other than the
Participant with respect to a proposed transfer to the same Proposed Transferee. If the Company exercises the Right of First 

  
 9 

 
Refusal, the Company and the Participant shall thereupon consummate the sale of the Transfer Shares to the Company on the terms set forth in the Transfer Notice within sixty (60) days after
the date the Transfer Notice is delivered to the Company (unless a longer period is offered by the Proposed Transferee); provided, however, that in the event the Transfer Notice provides for the payment for the Transfer Shares other than in cash,
the Company shall have the option of paying for the Transfer Shares by the present value cash equivalent of the consideration described in the Transfer Notice as reasonably determined by the Company. For purposes of the foregoing, cancellation of
any indebtedness of the Participant to any Participating Company shall be treated as payment to the Participant in cash to the extent of the unpaid principal and any accrued interest canceled. 

11.5 Failure to Exercise Right of First Refusal. If the Company fails to exercise the Right of First Refusal in full
(or to such lesser extent as the Company and the Participant otherwise agree) within the period specified in Section 11.4 above, the Participant may conclude a transfer to the Proposed Transferee of the Transfer Shares on the terms and
conditions described in the Transfer Notice, provided such transfer occurs not later than ninety (90) days following delivery to the Company of the Transfer Notice. The Company shall have the right to demand further assurances from the
Participant and the Proposed Transferee (in a form satisfactory to the Company) that the transfer of the Transfer Shares was actually carried out on the terms and conditions described in the Transfer Notice. No Transfer Shares shall be transferred
on the books of the Company until the Company has received such assurances, if so demanded, and has approved the proposed transfer as bona fide. Any proposed transfer on terms and conditions different from those described in the Transfer Notice, as
well as any subsequent proposed transfer by the Participant, shall again be subject to the Right of First Refusal and shall require compliance by the Participant with the procedure described in this Section 11. 

11.6 Transferees of Transfer Shares. All transferees of the Transfer Shares or any interest therein, other than the
Company, shall be required as a condition of such transfer to agree in writing (in a form satisfactory to the Company) that such transferee shall receive and hold such Transfer Shares or interest therein subject to all of the terms and conditions of
this Option Agreement, including this Section 11 providing for the Right of First Refusal with respect to any subsequent transfer. Any sale or transfer of any shares acquired upon exercise of the Option shall be void unless the provisions of
this Section 11 are met. 
 11.7 Transfers Not Subject to Right of First Refusal. The Right of First
Refusal shall not apply to any transfer or exchange of the shares acquired upon exercise of the Option if such transfer or exchange is in connection with an Ownership Change Event. If the consideration received pursuant to such transfer or exchange
consists of stock of a Participating Company, such consideration shall remain subject to the Right of First Refusal unless the provisions of Section 11.9 below result in a termination of the Right of First Refusal. 

11.8 Assignment of Right of First Refusal. The Company shall have the right to assign the Right of First Refusal at
any time, whether or not there has been an attempted transfer, to one or more persons as may be selected by the Company. 

  
 10 

 11.9 Early Termination of Right of First Refusal. The other provisions
of this Option Agreement notwithstanding, the Right of First Refusal shall terminate and be of no further force and effect upon (a) the occurrence of a Change in Control, unless the Acquiror assumes the Company’s rights and obligations
under the Option or substitutes a substantially equivalent option for the Acquiror’s stock for the Option, or (b) the existence of a public market for the class of shares subject to the Right of First Refusal. A “public
market” shall be deemed to exist if (i) such stock is listed on a national securities exchange (as that term is used in the Exchange Act) or (ii) such stock is traded on the over-the-counter market and prices therefor
are published daily on business days in a recognized financial journal. 
 12. STOCK
DISTRIBUTIONS SUBJECT TO OPTION AGREEMENT. 
 If, from time to time, there is any stock dividend, stock split or other change, as described in Section 9, in the character or amount of any of the outstanding stock of the corporation the stock of
which is subject to the provisions of this Option Agreement, then in such event any and all new, substituted or additional securities to which the Participant is entitled by reason of the Participant’s ownership of the shares acquired upon
exercise of the Option shall be immediately subject to the Right of First Refusal with the same force and effect as the shares subject to the Right of First Refusal immediately before such event. 

13. NOTICE OF SALES UPON DISQUALIFYING
DISPOSITION. 
 The Participant shall dispose of the shares acquired pursuant to the Option
only in accordance with the provisions of this Option Agreement. In addition, if the Notice designates this Option as an Incentive Stock Option, the Participant shall (a) promptly notify the Chief Financial Officer of the Company if the
Participant disposes of any of the shares acquired pursuant to the Option within one (1) year after the date the Participant exercises all or part of the Option or within two (2) years after the Date of Option Grant and (b) provide
the Company with a description of the circumstances of such disposition. Until such time as the Participant disposes of such shares in a manner consistent with the provisions of this Option Agreement, unless otherwise expressly authorized by the
Company, the Participant shall hold all shares acquired pursuant to the Option in the Participant’s name (and not in the name of any nominee) for the one-year period immediately after the exercise of the Option and the two-year period
immediately after Date of Option Grant. At any time during the one-year or two-year periods set forth above, the Company may place a legend on any certificate representing shares acquired pursuant to the Option requesting the transfer agent for the
Company’s stock to notify the Company of any such transfers. The obligation of the Participant to notify the Company of any such transfer shall continue notwithstanding that a legend has been placed on the certificate pursuant to the preceding
sentence. 
 14. LEGENDS. 

The Company may at any time place legends referencing the Right of First Refusal and any applicable federal, state or foreign securities
law restrictions on all certificates representing shares of stock subject to the provisions of this Option Agreement. The Participant shall, at the request of the Company, promptly present to the Company any and all certificates

  
 11 

 
representing shares acquired pursuant to the Option in the possession of the Participant in order to carry out the provisions of this Section. Unless otherwise specified by the Company, legends
placed on such certificates may include, but shall not be limited to, the following: 
 14.1 “THE SECURITIES EVIDENCED BY
THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND MAY NOT BE SOLD, TRANSFERRED, ASSIGNED OR HYPOTHECATED UNLESS THERE IS AN EFFECTIVE REGISTRATION STATEMENT UNDER SUCH ACT COVERING SUCH SECURITIES, THE SALE
IS MADE IN ACCORDANCE WITH RULE 144 OR RULE 701 UNDER THE ACT, OR THE COMPANY RECEIVES AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE COMPANY, STATING THAT SUCH SALE, TRANSFER, ASSIGNMENT OR HYPOTHECATION IS EXEMPT FROM THE REGISTRATION
AND PROSPECTUS DELIVERY REQUIREMENTS OF SUCH ACT.” 
 14.2 “THE SHARES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO
CERTAIN RESTRICTIONS ON TRANSFER AND REPURCHASE OPTIONS IN FAVOR OF THE CORPORATION OR ITS ASSIGNEE SET FORTH IN AN AGREEMENT BETWEEN THE CORPORATION AND THE REGISTERED HOLDER, OR SUCH HOLDER’S PREDECESSOR IN INTEREST, A COPY OF WHICH IS ON
FILE AT THE PRINCIPAL OFFICE OF THIS CORPORATION.” 
 14.3 “THE SHARES EVIDENCED BY THIS CERTIFICATE WERE ISSUED BY
THE CORPORATION TO THE REGISTERED HOLDER UPON EXERCISE OF AN INCENTIVE STOCK OPTION AS DEFINED IN SECTION 422 OF THE INTERNAL REVENUE CODE OF 1986, AS AMENDED (“ISO”). IN ORDER TO OBTAIN THE PREFERENTIAL TAX TREATMENT AFFORDED
TO ISOs, THE SHARES SHOULD NOT BE TRANSFERRED PRIOR TO [INSERT DISQUALIFYING DISPOSITION DATE HERE]. SHOULD THE REGISTERED HOLDER ELECT TO TRANSFER ANY OF THE SHARES PRIOR TO THIS DATE AND FOREGO ISO TAX TREATMENT, THE TRANSFER AGENT FOR THE
SHARES SHALL NOTIFY THE CORPORATION IMMEDIATELY. THE REGISTERED HOLDER SHALL HOLD ALL SHARES PURCHASED UNDER THE INCENTIVE STOCK OPTION IN THE REGISTERED HOLDER’S NAME (AND NOT IN THE NAME OF ANY NOMINEE) PRIOR TO THIS DATE OR UNTIL TRANSFERRED
AS DESCRIBED ABOVE.” 
 15. LOCK-UP
AGREEMENT. 
 The Participant hereby agrees that in the event
of any underwritten public offering of stock, including an initial public offering of stock, made by the Company pursuant to an effective registration statement filed under the Securities Act, the Participant shall not offer, sell, contract to sell,
pledge, hypothecate, grant any option to purchase or make any short sale of, or otherwise dispose of any shares of stock of the Company or any rights to acquire stock of the Company for such period of time from and after the effective date of such
registration statement as may be established by the underwriter for such public offering; provided, however, that such period of time shall not exceed one hundred eighty (180) days from the effective date of the registration statement to be
filed in connection with such public offering. The foregoing limitation shall not apply to shares registered in the public offering under the Securities Act. 

  
 12 

 16. RESTRICTIONS ON TRANSFER
OF SHARES. 
 No shares acquired upon exercise of the Option may be sold,
exchanged, transferred (including, without limitation, any transfer to a nominee or agent of the Participant), assigned, pledged, hypothecated or otherwise disposed of, including by operation of law, (a) unless a public market (as defined in
Section 11.9) then exists for the Stock, prior to the first to occur of an Ownership Change Event or the date occurring six (6) months after the Participant acquired such shares or (b) in any manner which violates any of the
provisions of this Option Agreement, and any such attempted disposition shall be void. The Company shall not be required (a) to transfer on its books any shares which will have been transferred in violation of any of the provisions set forth in
this Option Agreement or (b) to treat as owner of such shares or to accord the right to vote as such owner or to pay dividends to any transferee to whom such shares will have been so transferred. 

17. MISCELLANEOUS PROVISIONS. 

17.1 Further Instruments. The parties hereto agree to execute such further instruments and to take such further action as may
reasonably be necessary to carry out the intent of this Agreement. 
 17.2 Binding Effect. Subject to the restrictions on
transfer set forth herein, this Option Agreement shall inure to the benefit of and be binding upon the parties hereto and their respective heirs, executors, administrators, successors and assigns. 

17.3 Termination or Amendment. The Board may terminate or amend the Plan or the Option at any time; provided, however, that except
as provided in Section 8.2 in connection with a Change in Control, no such termination or amendment may adversely affect the Option or any unexercised portion hereof without the consent of the Participant unless such termination or amendment is
necessary to comply with any applicable law or government regulation. No amendment or addition to this Option Agreement shall be effective unless in writing. 
 17.4 Notices. Any notice required or permitted hereunder shall be given in writing and shall be deemed effectively given (except to the extent that this Option Agreement provides for effectiveness
only upon actual receipt of such notice) upon personal delivery, upon deposit in the United States Post Office, by registered or certified mail, or with an overnight courier service with postage and fees prepaid, addressed to the other party at the
address shown below that party’s signature or at such other address as such party may designate in writing from time to time to the other party. 
 17.5 Integrated Agreement. The Notice, this Option Agreement and the Plan constitute the entire understanding and agreement of the Participant and the Participating Company Group with respect to
the subject matter contained herein or therein and supersedes 

  
 13 

 
any prior agreements, understandings, restrictions, representations, or warranties among the Participant and the Participating Company Group with respect to such subject matter other than those
as set forth or provided for herein or therein. To the extent contemplated herein or therein, the provisions of the Notice and the Option Agreement shall survive any exercise of the Option and shall remain in full force and effect. 

17.6 Applicable Law. This Option Agreement shall be governed by the laws of the State of California as such laws are applied to
agreements between California residents entered into and to be performed entirely within the State of California. 
 17.7
Counterparts. The Notice may be executed in counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. 

  
 14 

					
	 ̈  Incentive Stock Option	  	Participant:	 	  

	 ̈  Nonstatutory Stock Option	  		 	
		  	Date:	 	  

 STOCK OPTION EXERCISE NOTICE 
 Tria Beauty, Inc. 
 Attention: Chief Financial Officer 

4160 Dublin Blvd., Suite 200 
 Dublin, CA 94568

 Ladies and Gentlemen: 
 1. Option. I was granted an option (the “Option”) to purchase shares of the common stock (the “Shares”) of Tria
Beauty, Inc. (the “Company”) pursuant to the Company’s 2004 Stock Plan (the “Plan”), my Notice of Grant of Stock Option (the
“Notice”) and my Stock Option Agreement (the “Option Agreement”) as follows: 
  

					
	 Date of Option Grant:
	  			
	 Number of Option Shares:
	  			
	 Exercise Price per Share:
	  	 	$                           
             	  

 2. Exercise of Option. I hereby elect to exercise the Option to purchase the following
number of Shares, all of which are Vested Shares in accordance with the Notice and the Option Agreement: 
  

					
	 Total Shares Purchased:
	  			
	 Total Exercise Price (Total Shares X Price per Share)
	  	 	$                           
             	  

 3. Payments. I enclose payment in full of the total exercise price for the Shares in the
following form(s), as authorized by my Option Agreement: 
  

					
	  ̈  Cash:
	  	 	$                           
             	  
	  ̈  Check:
	  	 	$                           
             	  
	  ̈  Tender of Company Stock:
	  	 	Contact Plan Administrator	  

 4. Tax Withholding. I authorize payroll withholding and otherwise will make adequate
provision for the federal, state, local and foreign tax withholding obligations of the Company, if any, in connection with the Option. If I am exercising a Nonstatutory Stock Option, I enclose payment in full of my withholding taxes, if any, as
follows: 
 (Contact Plan Administrator for amount of tax due.) 

 

					
	  ̈  Cash:
	  	 	$                           
             	  
	  ̈  Check:
	  	 	$                           
             	  

 5. Participant Information. 

 

			
	My address is:	 	  

		 	  

			
	My Social Security Number is:	 	  

 6. Notice of Disqualifying Disposition. If the Option is an Incentive Stock Option, I agree
that I will promptly notify the Chief Financial Officer of the Company if I transfer any of the Shares within one (1) year from the date I exercise all or part of the Option or within two (2) years of the Date of Option Grant. 

7. Binding Effect. I agree that the Shares are being acquired in accordance with and subject to the terms, provisions and
conditions of the Option Agreement, including the Right of First Refusal set forth therein, to all of which I hereby expressly assent. This Agreement shall inure to the benefit of and be binding upon my heirs, executors, administrators, successors
and assigns. 
 
 8. Transfer. I
understand and acknowledge that the Shares have not been registered under the Securities Act of 1933, as amended (the “Securities Act”), and that consequently the Shares must be held indefinitely unless they are
subsequently registered under the Securities Act, an exemption from such registration is available, or they are sold in accordance with Rule 144 or Rule 701 under the Securities Act. I further understand and acknowledge that the Company is
under no obligation to register the Shares. I understand that the certificate or certificates evidencing the Shares will be imprinted with legends which prohibit the transfer of the Shares unless they are registered or such registration is not
required in the opinion of legal counsel satisfactory to the Company. 
 I am aware that Rule 144 under the Securities Act,
which permits limited public resale of securities acquired in a nonpublic offering, is not currently available with respect to the Shares and, in any event, is available only if certain conditions are satisfied. I understand that any sale of the
Shares that might be made in reliance upon Rule 144 may only be made in limited amounts in accordance with the terms and conditions of such rule and that a copy of Rule 144 will be delivered to me upon request. 

 

 I understand that I am purchasing the Shares pursuant to the terms of the Plan, the Notice
and my Option Agreement, copies of which I have received and carefully read and understand. 
  

	
	Very truly yours,
	
	  

	(Signature)

  

			
	Receipt of the above is hereby acknowledged.
	
	TRIA BEAUTY, INC.
		
	By:	 	  

	Title:	 	  

	Dated:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00201-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00201-of-00352.parquet"}]]